CN115040644A - 新冠肺炎重组狂犬病病毒载体疫苗 - Google Patents

新冠肺炎重组狂犬病病毒载体疫苗 Download PDF

Info

Publication number
CN115040644A
CN115040644A CN202111189847.5A CN202111189847A CN115040644A CN 115040644 A CN115040644 A CN 115040644A CN 202111189847 A CN202111189847 A CN 202111189847A CN 115040644 A CN115040644 A CN 115040644A
Authority
CN
China
Prior art keywords
leu
thr
ser
val
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111189847.5A
Other languages
English (en)
Other versions
CN115040644B (zh
Inventor
步志高
帅磊
王喜军
葛金英
温志远
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harbin Veterinary Research Institute of CAAS
Original Assignee
Harbin Veterinary Research Institute of CAAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harbin Veterinary Research Institute of CAAS filed Critical Harbin Veterinary Research Institute of CAAS
Publication of CN115040644A publication Critical patent/CN115040644A/zh
Application granted granted Critical
Publication of CN115040644B publication Critical patent/CN115040644B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/542Mucosal route oral/gastrointestinal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/54Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541Mucosal route
    • A61K2039/543Mucosal route intranasal
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/20011Rhabdoviridae
    • C12N2760/20111Lyssavirus, e.g. rabies virus
    • C12N2760/20134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20022New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/20011Coronaviridae
    • C12N2770/20034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

本发明提供一种包含改造的SARS‑CoV‑2的刺突蛋白(S’)的疫苗组合物,用于预防新型冠状病毒的感染,尤其是针对哺乳动物的新型冠状病毒的感染。

Description

新冠肺炎重组狂犬病病毒载体疫苗
技术领域
本发明涉及针对哺乳动物新型冠状病毒的预防性疫苗的组合物和方法,进一步涉及针对哺乳动物新型冠状病毒和狂犬病病毒的预防性疫苗的组合物和方法。
背景技术
新型冠状病毒性疾病(COVID-19)是由新型冠状病毒(SARS-CoV-2)引起的传播能力极强的人兽共患病(Chan,J.F.W.,et al.,A familial cluster of pneumoniaassociated with the 2019novel coronavirus indicating person-to-persontransmission:a study of a family cluster.Lancet,2020.395(10223):p.514-523;Zhu,N.,et al.,A Novel Coronavirus from Patients with Pneumonia in China,2019.New England Journal Of Medicine,2020.382(8):p.727-733.)。COVID-19在全球仍然持续流行,不断危害人类生命健康。SARS-CoV-2的动物感染谱较为广泛,能感染蝙蝠、狮子、老虎、恒河猴、食蟹猴、水貂、雪貂、猫等多种强流动性动物。目前,欧洲和北美大量养殖场水貂发生新冠病毒感染,已出现水貂将新冠病毒传播给人类的个案,近2千万只水貂被扑杀,给欧美水貂产业带来毁灭性打击,对我国的水貂产业也构成严重威胁。值得注意的是,SARS-CoV-2高度易感的水貂和猫在全球范围内广泛存在,流动性极强,这将极大地增加了人间COVID-19的传播风险。到目前为止仍缺少有效预防COVID-19的方法,其中间宿主和传播途径也有待进一步证实,从而加大了防控COVID-19的难度。疫苗是阻断、消除人间COVID-19最有效最有潜力的途径。
寻找抗原性更优的SARS-CoV-2病毒的抗原依然是目前研究的热点。进一步制备用于动物的COVID-19的疫苗是阻断、消除COVID-19在动物之间以及人畜之间传播的最有效的手段。
RABV属于弹状病毒科(Rhaboviridae)狂犬病病毒属(Lyssaavirus)的狂犬病病毒,其基因组RNA(vRNA)严格保守有序地编码5种结构蛋白:核蛋白(N),磷蛋白(P),基质蛋白(M),糖蛋白(G)和大聚合酶蛋白(L)。RABV具有基因组结构简单、反向遗传技术成熟、能稳定容纳并高水平表达外源基因、能同时有效诱导载体和外源蛋白相关的免疫反应等特点,可作为优良的病毒载体[Bukreyev,A.,et al.,Nonsegmented negative-strand virusesas vaccine vectors.ournal Of Virology,2006.80(21):p.10293-10306.]。本研究团队前期在RABV重组野生Evelyn-Rokitnicki-Abelseth(rERA)株反向遗传操作载体平台上,构建出G333位点突变成谷氨酸(E)的分子修饰狂犬病病毒ERA疫苗株(rERAG333E).[Shuai,L.,et al.,Genetically modified rabies virus ERA strain is safe and induceslong-lasting protective immune response in dogs after oralvaccination.Antiviral Res,2015.121:p.9-15.];以候选疫苗株rERAG333E为活病毒载体,构建出一系列表达埃博拉病毒、尼帕脑炎病毒G蛋白的重组RABV,均具有良好的安全性和免疫原性。[Shuai,L.,et al.,Genetically modified rabies virus-vectored Ebolavirus disease vaccines are safe and induce efficacious immune responses inmice and dogs.Antiviral Res,2017.146:p.36-44;Shuai,L.,et al.,Immune responsesin mice and pigs after oral vaccination with rabies virus vectored Nipahdisease vaccines.Vet Microbiol,2020.241:p.108549.]。因此,RABV rERAG333E株是良好的病毒载体用于疫苗的创制。
从上述内容可以看出,寻找抗原性更优的SARS-CoV-2蛋白提供针对COVID-19的疫苗,尤其是针对哺乳动物的COVID-19的疫苗是迫切需要的,因此本发明人在多年工作的积累下开发了这样的新的疫苗来预防新型冠状病毒的感染,尤其是针对哺乳动物的新的疫苗来预防新型冠状病毒的感染。本发明提供了这种预防性疫苗。
发明内容
SARS-CoV-2的刺突蛋白(S)含有S1和S2两个亚基,其中S1具有SARS-CoV-2与宿主细胞结合的RBD区,发挥病毒吸附宿主细胞的功能,S2亚基发挥病毒-宿主细胞吸附后膜融合的功能。S蛋白是刺激机体发挥免疫原性的重要靶标蛋白,是COVID-19疫苗创制的基础。
本发明提供了包含改造的SARS-CoV-2的刺突蛋白(S’)的疫苗组合物,该改造的SARS-CoV-2的刺突蛋白(S’)包含组织型纤溶酶原激活因子信号肽。
在一个实施方案中,本发明提供了包含改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物的疫苗组合物,其中改造的SARS-CoV-2的刺突蛋白(S’)包括S蛋白基因信号肽替换为组织型纤溶酶原激活因子信号肽。
在一个实施方案中,该疫苗组合物包含改造的SARS-CoV-2的刺突蛋白(S’),该改造的SARS-CoV-2的刺突蛋白(S’)选自命名为S’-TP-1(SEQ ID NO:1)、S’-TP-2(SEQ ID NO:2)的刺突蛋白。
在一个实施方案中,该改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物包含来自SEQ ID NO:1或SEQ ID NO:2的核苷酸序列。
在一个实施方案中,该改造的SARS-CoV-2的刺突蛋白(S’)及或其免疫原性衍生物与SARS-CoV-2的刺突蛋白(S)相比优选Furin裂解位点突变缺失,进一步优选6个氨基酸位点脯氨酸突变(F817P、A892P、A899P、A942P、K986P、V987P)可表达出完整、空间结构更稳定、免疫原性更高的SARS-CoV-2S’蛋白。
在一个实施方案中,该改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物由病毒载体编码。
在一个实施方案中,该改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物由病毒载体编码,所属病毒载体选自腺病毒载体、腺相关病毒载体、逆转录病毒载体、痘病毒载体、疱疹病毒载体、新城疫病毒载体、流感病毒载体、狂犬病病毒载体。
在一个实施方案中,该疫苗组合物优选包含将狂犬病毒疫苗株(rERAG333E)的非致病性骨架与新型改造的SARS-CoV-2的刺突蛋白(S’)结合的重组嵌合型狂犬病毒。
在一个实施方案中,重组嵌合型狂犬病毒病毒被命名为重组RABV rERAG333E-coS’(SEQ ID NO:3),在coS的基础上构建了表达coS蛋白基因信号肽替换成tPA、Furin裂解位点突变缺失和6个脯氨酸突变的SARS-CoV-2S蛋白基因突变体tPASopti6(S6P)的重组RABVrERAG333E-S6P(SEQ ID NO:4)。在一个实施方案中,疫苗是口服疫苗、活疫苗、经修饰的活疫苗、灭活疫苗、减毒疫苗、或亚单位疫苗。在另一个实施方案中,疫苗组合物包含含有改造的SARS-CoV-2的刺突蛋白(S’)的狂犬病病毒载体RABV rERAG333E。
在一个具体实施方案中,疫苗是口服疫苗,在另一个具体实施方案中,疫苗是灭活疫苗。在另一个具体的实施方案中,疫苗是亚单位疫苗或灭活的全病毒疫苗。
在一个方面,根据本发明的疫苗组合物还包含佐剂。在一个实施方案中,佐剂选自:水包油佐剂、聚合物和水佐剂、油包水佐剂、氢氧化铝佐剂、维生素E佐剂及其组合。在一个具体实施方案中,佐剂包含油乳剂,该油乳剂包含聚氧乙烯-聚氧丙烯嵌段共聚物、角鲨烷、聚氧乙烯山梨醇酐单油酸酯和缓冲盐溶液(SP-油)。在一个实施方案中,该组合物还包含药学上可接受的载体。
在另一个实施方案中,该疫苗组合物还可以包含至少一种额外的抗原。在某些实施方案中,至少一种额外的抗原保护性地抵御可以引起哺乳动物疾病的微生物。
在另一个实施方案中,提供了嵌合核酸分子,其包含编码非致病性狂犬病病毒载体RABV rERAG333E的核酸分子和编码改造的SARS-CoV-2的刺突蛋白(S’)的氨基酸(SEQ IDNO:5),即改造的SARS-CoV-2的刺突蛋白(S’)的核酸分子在coS的基础上构建了表达coS蛋白基因信号肽替换成tPA,进一步改造的SARS-CoV-2的刺突蛋白(S’)的核酸分子在coS的基础上构建了表达coS蛋白基因信号肽替换成tPA,Furin裂解位点突变缺失和6个脯氨酸突变的SARS-CoV-2S蛋白基因突变体tPASopti6(S6P)(SEQ ID NO:6)
本发明还提供了保护哺乳动物免受新型冠状病毒SARS-CoV-2和狂犬病病毒(RABV)感染的方法。该方法包括向哺乳施用免疫有效量的本发明公开的疫苗组合物、嵌合核酸分子、或病毒载体。在多种实施方案中,该方法包括通过选自经口服、胃肠道外、经鼻、皮内和经皮的一种或多于一种途径向哺乳动物施用疫苗组合物、嵌合核酸分子或病毒载体。在另一个实施方案中,疫苗组合物、嵌合核酸分子或病毒载体以单剂量施用。在另一个实施案中,组合物与至少一种额外的抗原联合施用,该额外的抗原保护性地抵御可以引起哺乳动物疾病的微生物,其实施例如上所述。
附图说明
图1:重组RABV rERAG333E/coS和rERAG333E/S6P株的构建及鉴定。(A)重组RABVrERAG333E/coS和rERAG333E/S6P株的构建示意图。coS蛋白基因为哺乳动物密码子偏噬性密码子优化的SARS-CoV-2S蛋白基因;S6P蛋白基因为包含组织型纤溶酶原激活因子(Tissueplasminogen activator,tPA)信号肽基因、6个突变位点及furin裂解位点删除突变的SARS-CoV-2S蛋白基因突变体;coS和S6P蛋白基因分别插入至rERAG333E株全长cDNA的P、M基因间的Pme I位点处。(B)重组RABVs的间接免疫荧光(IFA)鉴定。(C)重组RABVs的SARS-CoV-2S蛋白在感染BSR细胞中的western blot鉴定。(D)重组RABVs在BSR细胞上的生长动力学分析。病毒滴度经过四次平行试验确定,并以lg FFU/mL表示。通过T检验进行重组RABVs和亲本株之间不同时间点病毒滴度的差异性分析,“*”为0.01<P<0.05,。
图2:重组RABV rERAG333E/coS和rERAG333E/S6P株的小鼠体内致病力分析。分别将重组RABVs和rERAG333E的活病毒按5×107PFU/100μL/只的剂量经肌肉(A)、口服(B)途径接种感染6周龄BALB/c小鼠,6只/组,连续监测21天,记录体重变化情况。另设PBS接种组小鼠作为平行对照。
图3:重组RABV rERAG333E/coS和rERAG333E/S6P株在小鼠上的免疫原性分析。将重组病毒rERAG333E/coS、rERAG333E/S6P和亲本株rERAG333E分别按5×107PFU/100μL/只的剂量活病毒口服免疫接种(orally)或经β-丙内酯灭活混以入10%的MontanideTM GEL 02佐剂后按等同于5×107PFU/100μL/只剂量的灭活疫苗肌肉免疫接种(i.m.)6只6周龄BALB/c小鼠;免疫后21天按相同剂量、途径加强免疫。各组小鼠定期采血,免疫前、初次免疫后第21天的组内6只小鼠血清混合、加强免疫后第14天的每只小鼠血清分别用于SARS-CoV-2S蛋白特异性IgG抗体(A)、SARS-CoV-2中和抗体(B)和RABV中和抗体(C)检测。通过T检验进行重组RABVs和亲本株之间抗体水平的差异性分析,“*”为0.01<P<0.05,“**”为0.001<P<0.01,“***”为0.0001<P<0.001,“****”为0.00001<P<0.0001。
图4:重组RABV rERAG333E/coS和rERAG333E/S6P株在小鼠上的攻毒保护效力分析。小鼠在经口服(A、C)或灭活肌肉途径(B、D)加强免疫后14天经鼻内途径按103.6PFU/50μL/只的剂量接种SARS-CoV-2HRB26M毒株。每组6只小鼠分别在攻毒后3天和5天时处死3只,取鼻甲(Tubinate)和肺(Lung)组织,通过qPCR及细胞蚀斑计数试验检测样品中的病毒载量(A、B)及活病毒数(C、D)。
具体实施方式
虽然下面详细讨论了本发明各种实施方案的进行和使用,但应该理解,本发明提供了许多可以在各种特定情况下使用的可适用的发明概念。这里讨论的具体实施方案仅说明进行和使用本发明的具体方式,并不限制本发明的范围。
S蛋白单体情况下,RBD区存在关闭沉降和上升开放两种状态。RBD的关闭沉降状态覆盖了S2亚基部分氨基酸,削弱S蛋白的免疫原性;RBD上升开放状态则是解离S2亚基,可充分发挥其免疫原性。相较野生型S蛋白,K986P、V987P这两个联合突变可使具有高免疫原性和可移动特性的RBD处于稳定的上升开放状态,提高表达S蛋白的免疫原性(Henderson R,Edwards R J,Mansouri K,Janowska K,Stalls V,Gobeil S M C,Kopp M,Li D,Parks R,Hsu A L,Borgnia M J,Haynes B F,Acharya P.2020.Controlling the SARS-CoV-2spikeglycoprotein conformation.Nature structural&molecular biology,27,925-933.5);F817P、A892P、A899P、A942P突变则可使S蛋白的表达量增高约10倍,并具有耐热、室温贮藏和3次冻融循环的能力(Hsieh C L,Goldsmith J A,Schaub J M,DiVenere A M,Kuo H C,Javanmardi K,Le K C,Wrapp D,Lee A G,Liu Y,Chou C W,Byrne P O,Hjorth C K,Johnson N V,Ludes-Meyers J,Nguyen A W,Park J,Wang N,Amengor D,Lavinder J J,Ippolito G C,Maynard J A,Finkelstein I J,McLellan J S.2020.Structure-baseddesign of prefusion-stabilized SARS-CoV-2spikes.Science,369,1501-150);SARS-CoV-2S蛋白基因的Furin裂解位点突变缺失可保留了S’蛋白的预融合构像,不裂解成S1和S2亚基,提高了S’蛋白的抗原性。
本发明通过例举性的实施RABV口服疫苗株rERAG333E载体平台,通过反向遗传技术构建了分别表达哺乳动物密码子偏噬性密码子优化的SARS-CoV-2S蛋白基因(coS’)和表达含组织型纤溶酶原激活因子(Tissue plasminogen activator,tPA)信号肽基因的coS’蛋白基因突变体tPASopti6(S6P)的重组RABV rERAG333E-coS’和rERAG333E-S6P。重组RABVrERAG333E-coS’和rERAG333E-S6P均具有与亲本株rERAG333E相似的细胞培养生长特性和良好的生物安全性;相较rERAG333E-coS’,rERAG333E-S6P口服免疫和作为灭活疫苗肌肉免疫BABL/c小鼠不仅保持了rERAG333E株良好的RABV免疫原性,还可诱导更高水平的SARS-CoV-2抗S蛋白特异性IgG抗体和中和抗体反应,并且可实现SARS-CoV-2小鼠适应株在小鼠上呼吸道和肺部的攻毒完全保护,表明重组RABV rERAG333E-S6P株能够用于新冠肺炎与狂犬病动物用口服二联疫苗和人用灭活二联疫苗。
以狂犬病毒为载体,可同时对狂犬病毒进行免疫,对狂犬病毒的易感宿主人、动物均可实现免疫功能。
为了便于理解本发明,下面定义了许多术语。本发明定义的术语具有本发明相关领域中普通技术人员通常理解的含义。
如本发明所用术语“包含”、“包括”、“含有”旨在表示组合物和方法包括所列举的要素,但不排除其他要素。
术语“抗原”是指可以在动物中刺激抗体或T细胞应答或两者的产生的化合物、组合物或免疫原性物质,其包括口服、注射或吸收到动物体内的组合物。可以对整个分子或分子的一部分(例如表位或半抗原)产生免疫应答。
如本发明所定义的,“免疫原性组合物或免疫组合物”是指包含至少一种抗原的物质的组合物,该抗原在宿主中引发对感兴趣的组合物或疫苗的细胞的免疫应答和/或抗体介导的免疫应答。
本发明所用的“佐剂”是指由一种或多于一种增强对抗原的免疫应答的物质组成的组合物。佐剂如何起作用的机制尚不完全清楚。一些佐剂被认为通过缓慢释放抗原来增强免疫应答,而其他佐剂本身具有强免疫原性并被认为起到协同作用。
本发明所用的术语“哺乳动物”是指包括人、及对狂犬病毒和新冠病毒病毒的哺乳动物,例如人、蝙蝠、狮子、老虎、恒河猴、食蟹猴、水貂、雪貂、猫、狗等。
如本文所用术语“药学上可接受的载体”是指用于包含可以口服或注射到宿主中且没有副作用的疫苗抗原的流体载体。本领域已知的合适的药学上可接受的载体包括但不限于无菌水、盐水、葡萄糖、右旋糖或缓冲溶液等。载体可包括助剂包括但不限于稀释剂、稳定剂(糖和氨基酸)、防腐剂、润湿剂、乳化剂、pH缓冲剂、黏度增强添加剂、着色剂等。
如本文所用术语“疫苗组合物”包括在药学上可接受的载体中的至少一种抗原或免疫原,其可用于在宿主中诱导免疫应答。疫苗组合物可以按剂量施用并通过医学或兽医领域技术人员熟知的技术施用,同时考虑例如接受体动物的年龄、性别、体重、物种和状况、以及给药途径等因素。给药途径可以是经皮(通过皮内、经皮、皮下、肌内途径而穿过皮肤或通过口腔、鼻腔、肛门、阴道而穿过黏膜)或通过肠胃外途径(静脉内或腹膜内)。疫苗组合物可以单独施用,或者可以与其他治疗或疗法共同施用或按顺序施用。给药形式可包括混悬剂、糖浆剂或酏剂,以及用于肠胃外、皮下、皮内、肌内或静脉内给药(例如注射给药)的制剂,例如无菌混悬剂或乳剂。疫苗组合物可以以喷雾形式给药或混合于食物和/或水中或与合适的载体、稀释剂、或赋形剂如无菌水、生理盐水、葡萄糖等混合递送。该组合物可含有辅助物质,如润湿剂或乳化剂、pH缓冲剂、佐剂、凝胶化或黏度增强添加剂、防腐剂、调味剂、着色剂等,这取决于给药途径和所需制剂。
为了公开的完整性,包括了以下实施例以说明制备本发明组合物和复合物的方法以及呈现组合物的某些特征。这些实施例决不旨在限制本公开的范围或教导。
实施例1:材料与方法
1.1细胞、重组质粒、病毒株、主要试剂及仪器
BSR细胞、rERAG333E株全长cDNA质粒pCI-rERAG333E及辅助核蛋白pCI-ERAN、磷蛋白pCI-ERAP和聚合酶大蛋白pCI-ERAL均由本实验室保存。弱毒疫苗株rERAG333E株由本实验室拯救并保存。SARS-CoV-2鼠适应株HRB26M株由本实验室分离、适应并保存。Phanta高保真DNA聚合酶、One Step Cloning Kit购自Vazyme;限制性内切酶Pme I购自NEB公司;质粒提取试剂盒购自QIAGEN公司;胎牛血清、DMEM培养基购自Gibco公司;磷酸钙转染试剂盒、RNA提取试剂TRIzol及鼠源反转录酶(M-MLV)试剂盒均购自Invitrogen;小鼠抗SARS-CoV-2S蛋白多克隆抗体、犬抗RABV多克隆抗体由本实验室制备和保存;FITC标记的兔抗犬IgG和TRITC标记的山羊抗鼠IgG抗体、hoechst 33342染料购自Abcam;共聚焦激光扫描显微镜为ZEISS公司产品。
1.2质粒构建
根据合成基因Sopti和tPASopti6P序列信息,利用引物将coS和S6P基因分别引入rERAG333E株全长cDNA的P、M基因间的Pme I位点处(表1)。采用PCR方法,以pBlue-Sopti为模板,用引物EcoSF和EcoSR扩增coS蛋白基因;以pBlue-tPASopti6P为模板,用引物ES6PF和EcoSR扩增S6P、S6PG蛋白基因。rERAG333E株全长cDNA质粒pCI-rERAG333E经过限制性内切酶Pme I处理线性化得到全长线性片段pCI-rERAG333E。利用One Step Cloning Kit将片段coS、S6P分别经过一步克隆至pCI-rERAG333E的Pme I位点处,获得重组全长cDNA质粒pCI-rERAG333E/coS、pCI-rERAG333E/S6P(图1A)。
表1表达SARS-CoV-2 coS和S6P基因重组rERAG333E全基因组质粒所用引物
Figure BDA0003298701970000091
1.3重组RABVs的拯救
采用磷酸钙转染法将5μg pCI-rERAG333E/coS、pCI-rERAG333E/S6P分别与一套RABV拯救辅助质粒系统(2.5μg pCI-ERAN,1.25μg pCI-ERAP和1.25μg pCI-ERAL)共转染至6孔板中汇合度约80%的BSR细胞中,4天后收集细胞孔内上清液,并通过在BSR细胞上继续盲传3代以提高病毒滴度。将待鉴定的F3代重组病毒保存至-70℃,并命名为rERAG333E/coS和rERAG333E/S6P。
1.4重组RABVs的间接免疫荧光(IFA)检测
将rERAG333E和F3代重组RABVs按多重感染复数(MOI)约0.1感染BSR细胞。接种细胞37℃培养48h后3%多聚甲醛固定20min,以抗RABV犬血清和抗SARS-CoV-2S蛋白小鼠血清为一抗,以绿色荧光素(FITC)标记的兔抗犬IgG和TRITC标记的山羊抗鼠IgG为二抗,进行荧光染色。以hoechst 33342对细胞进行染核处理。使用激光共聚焦显微镜对染色的细胞单层进行观察并拍照。
1.5重组RABVs的RT-PCR鉴定
采用TRIzol法提取F3代重组RABVs基因组RNA。根据RABV疫苗株ERA全基因序列(EF206707.1),设计一对引物NXF(5'-GATCCTCAGGGATACTCTTG-3')和NXR(5'-AGCCACAAGTCATCGTCATC-3'),进行RT-PCR扩增,对扩增的PCR产物进行测序分析。
1.6重组RABVs的SARS-CoV-2S蛋白在感染细胞中的表达鉴定
将rERAG333E/coS和rERAG333E/S6P和亲本株rERAG333E分别以多重感染复数(MOI)为0.5的剂量感染于汇合度约80%的BSR细胞,感染48h后收集细胞,经细胞裂解液裂解后进行SDS-PAGE电泳并将蛋白转印至NC膜,5%脱脂乳封闭过夜。利用鼠抗SARS-CoV-2S蛋白小鼠血清为一抗,Alexa Fluor 680标记的驴抗小鼠IgG为二抗,进行western blot鉴定。同时设置空白细胞作为平行试验对照。
1.7重组RABVs的体外生长动力学曲线的测定
将rERAG333E/coS和rERAG333E/S6P和亲本株rERAG333E分别以多重感染复数(MOI)为0.01的剂量感染于汇合度约80%的BSR细胞,37℃孵育1小时后,用PBS(pH7.4)洗涤细胞两次,然后加入维持液,置于37℃含5%CO2的培养箱。分别于接毒24h、48h、72h、96h、120h、144h后收获含病毒的上清液,均在BSR细胞上进行滴定,以此绘制病毒在不同细胞上的生长动力学曲线。
1.8实验动物及动物实验
6周龄雌性BALB/c小鼠购自北京维通利华实验动物技术有限公司(Vital River)。小鼠实验严格按照“实验动物护理和使用指南”中的建议开展,并经中国农业科学院哈尔滨兽医研究所(HVRI,CAAS)动物护理和伦理委员会(IACEC)机构批准。所有小鼠的SARS-CoV-2接种实验均在国家动物疫病防控高级别生物安全实验室四级实验室(BSL-4)中进行。
1.9重组RABVs在BALB/c小鼠上的的致病力分析
为了评估重组RABVs作为新冠肺炎候选口服疫苗和灭活注射用疫苗的安全性,分别将重组RABVs和rERAG333E的活病毒按5×107PFU/100μL/只的剂量分别肌肉、口服接种6周龄BALB/c小鼠,6只/组;同时,用PBS按100μL/只的剂量分别肌肉、口服接种6只小鼠,作为对照进行平行试验。记录感染后每天各组小鼠的体重及临床发病情况,持续21天。
1.10重组RABVs在BALB/c小鼠上的免疫原性评价
为了评估重组病毒rERAG333E/coS、rERAG333E/S6P和亲本株rERAG333E分别按5×107PFU/100μL/只的剂量活病毒口服免疫接种6只6周龄BALB/c小鼠小鼠;同时,将重组RABVs和rERAG333E经β-丙内酯灭活后加入10%的MontanideTM GEL02(SEPPIC)佐剂,混匀后分别按等同于5×107PFU/100μL/只剂量的灭活疫苗i.m.免疫接种6只小鼠;免疫后21天按相同剂量、途径加强免疫。各组小鼠于免疫前、初次免疫后第21天和加强免疫后第14天经眶下静脉丛采血,分离血清,在56℃水浴灭活30min,免疫前、初次免疫后第21天的组内6只小鼠血清混合、加强免疫后第14天的每只小鼠血清分别用于SARS-CoV-2S蛋白特异性IgG抗体、中和抗体和RABV中和抗体检测。
1.10重组RABVs在BALB/c小鼠上的攻毒保护效力评价
上述各组免疫小鼠在加强免疫后第14天时经鼻内途径按103.6PFU/50μL/只的剂量接种SARS-CoV-2HRB26M毒株。每组6只小鼠分别在攻毒后3天和5天时随机被处死3只,通过qPCR及细胞蚀斑计数试验检测鼻甲和肺内的病毒载量及活病毒数。
实施例2:实验结果
2.1重组RABV的拯救与鉴定
在RABV疫苗株rERAG333E反向遗传操作系统基础上,利用PCR法将哺乳动物密码子偏噬性密码子优化的SARS-CoV-2S蛋白基因(coS)和SARS-CoV-2S蛋白基因高效表达且空间结构稳定的突变体tPASopti6(S6P)分别克隆至pCI-rERAG333E的Pme I位点。经测序鉴定后成功构建pCI-rERAG333E/coS和pCI-rERAG333E/S6P,并用于拯救rERAG333E/coS和rERAG333E/S6P毒株(图1A)。
为鉴定重组RABV rERAG333E/coS和rERAG333E/S6P的SARS-CoV-2S蛋白基因在细胞内的表达,将rERA-N/mCherry感染BSR细胞,采用IFA的方法染色,然后通过共聚焦激光扫描显微镜观察。结果显示,两株重组RABVs均呈现SARS-CoV-2S蛋白和RABV G蛋白的共表达,rERAG333E仅呈现针对RABV G蛋白抗体的阳性结果(图1B)。结果表明,重组RABVs的SARS-CoV-2S蛋白均有效表达,并且具有RABV相应的生物学活性。
为了进一步鉴定重组RABVs的SARS-CoV-2S蛋白的正确表达,分别将重组RABVs和rERAG333E感染的BSR细胞和空白对照BSR细胞制备裂解液,进行Western blot分析。结果显示,以SARS-CoV-2S蛋白小鼠血清为一抗进行WB检测,rERAG333E/coS、rERAG333E/S6P接种的细胞样品出现特异性条带与相应外源蛋白预期大小相符;而rERAG333E感染的BSR细胞和空白对照BSR细胞样品无特异条带(图1C)。结果表明,coS、S6P蛋白能在重组RABVs感染细胞中正确表达,并具有良好的反应原性。
为了比较重组RABVs和rERAG333E在BSR细胞上的生长动力学特点,将重组RABVs和rERAG333E分别按MOI为0.01的剂量感染BSR细胞后定时取样滴定病毒滴度。结果显示,在病毒感染BSR后48~120h间重组RABVs的滴度均显著低于亲本株的滴度;在感染后96h重组RABVs和rERAG333E滴度均达到的峰值,其中重组RABVs最高生长滴度为107.68~107.77FFU/mL,rERAG333E最高生长滴度为108.15FFU/mL(图1D)。结果表明,SARS-CoV-2S蛋白基因的插入不影响重组RABVs的体外生长性状,但降低了重组RABVs的体外增殖效率。
2.2SARS-CoV-2S蛋白基因的插入不影响RABV载体对小鼠的致病力
为了评估重组RABVs作为新冠肺炎候选口服疫苗和灭活注射用疫苗的安全性,分别将重组RABVs和rERAG333E的活病毒按5×107PFU/100μL/只的剂量分别肌肉、口服接种6周龄BALB/c小鼠。结果显示,重组RABVs和rERAG333Ei.m.接种(图2A)或口服接种(图2B)后的全部成年小鼠均未发生任何疾病或死亡情况,各组间成年小鼠的体重均平稳增长且无显著差异。结果表明,coS和S6P基因的插入未增加rERAG333E的致病力与亲本株相似,重组RABVs肌肉和口服接种对小鼠均无致病力。
2.3rERAG333E/S6P口服或灭活免疫小鼠均能诱导SARS-CoV-2和RABV中和抗体反应
为了评估重组RABVs作为新冠肺炎候选口服疫苗和灭活注射用疫苗的免疫原性,分别将重组RABVs和rERAG333E的活病毒按5×107PFU/100μL/只的剂量口服免疫6周龄BALB/c小鼠,或β-丙内酯灭活、混以10%的MontanideTM GEL 02佐剂后分别按等同于5×107PFU/100μL/只剂量的灭活疫苗肌肉免疫6周龄BALB/c小鼠。
活病毒口服免疫结果显示,rERAG333E/S6P免疫组小鼠在初次免疫后21天均产生低水平抗S蛋白特异性IgG抗体(图3A)和中和抗体(图3B),而rERAG333E/coS和rERAG333E免疫组均未检测到;rERAG333E/S6P免疫组小鼠加强免疫后14天均产生增强的抗S蛋白特异性IgG抗体和中和抗体反应,中和抗体滴度均介于32至256,显著高于rERAG333E/coS和rERAG333E免疫组;重组RABVs和rERAG333E免疫组小鼠初免后21天均产生RABV中和抗体,加强免疫后均显著增高中和抗体水平,平均滴度为5.09~6.23IU/mL,且重组RABVs与亲本株之间及重组RABVs之间均无显著性差异(图3C)。以上结果表明,rERAG333E/S6PG在小鼠上具有良好的SARS-CoV-2和RABV口服免疫原性。
病毒灭活肌肉免疫结果显示,重组RABVs免疫组小鼠在初次免疫后21天均产生抗S蛋白特异性IgG抗体(图3A)和中和抗体(图3B),而亲本株rERAG333E免疫组未检测到;rERAG333E/S6P免疫组小鼠加强免疫后14天均产生高水平的抗S蛋白特异性IgG抗体和中和抗体反应,中和抗体滴度均介于256至2048,显著高于rERAG333E/coS和rERAG333E免疫组;重组RABVs和亲本株免疫组小鼠初免后21天均产生RABV中和抗体,加强免疫后均显著增高中和抗体水平,平均滴度为12.31~14.45IU/mL,且重组RABVs与亲本株和重组RABVs之间均无显著性差异(图3C)。以上结果表明,rERAG333E/S6P灭活免疫小鼠具有良好的SARS-CoV-2和RABV免疫原性。
2.4rERAG333E/S6P口服或灭活免疫小鼠能提供完全的SARS-CoV-2攻毒保护效力
上述各组免疫小鼠在加强免疫后第14天时经鼻内途径按103.6PFU/50μL/只的剂量接种SARS-CoV-2HRB26M毒株。活病毒口服免疫攻毒结果显示,rERAG333E/S6P免疫组所有小鼠(3/3)在攻毒后第3天和第5天鼻甲和肺均未检测到病毒载量(图4A)和活病毒(图4C);rERAG333E/coS免疫组第3天和第5天鼻甲检测到病毒载量均值为8.41、6.32log(copies/g)的病毒载量,肺检测到病毒载量均值为8.30、3.84log(copies/g)的病毒载量,均显著高于rERAG333E/S6P各组织、时间点的病毒载量(图4A),同时在第3天部分鼻甲(2/3)和肺(1/3)检测到活病毒,均值为2.98、2.59log(PFU/g)(图4C);亲本株rERAG333E免疫组所有小鼠(3/3)在攻毒后第3天和第5天鼻甲检测到病毒载量均值为8.93、7.71log(copies/g)的病毒载量,肺检测到病毒载量均值为10.07、8.15log(copies/g)的病毒载量,均显著高于rERAG333E/S6P各组织、时间点的病毒载量(图4A),并且所有小鼠(3/3)在攻毒后第3天和第5天鼻甲检测到均值为4.58、3.69log(PFU/g)的活病毒量,肺检测到均值为6.22、3.91log(PFU/g)的病毒载量,均显著高于rERAG333E/S6P免疫小鼠各组织、时间点的病毒载量(图4C)。结果表明,rERAG333E/S6P在小鼠上具有完全的口服免疫SARS-CoV-2攻毒保护效力,有潜力作为动物新冠肺炎口服疫苗。
病毒灭活肌肉免疫攻毒结果显示,rERAG333E/S6P免疫组所有小鼠(3/3和3/3)在攻毒后第3天和第5天鼻甲和肺均未检测到病毒载量(图4B)和活病毒(图4D);rERAG333E/coS免疫组第3天和第5天鼻甲检测到病毒载量均值为7.11、4.09log(copies/g)的病毒载量,肺均未检测到病毒载量(图4B),同时在第3天部分鼻甲(2/3)检测到活病毒,均值为2.39(PFU/g)(图4D);亲本株rERAG333E免疫组所有小鼠(3/3)在攻毒后第3天和第5天鼻甲检测到病毒载量均值为9.06、8.02log(copies/g)的病毒载量,肺检测到病毒载量均值为9.16、7.16log(copies/g)的病毒载量,均显著高于重组RABVs免疫小鼠各组织、时间点的病毒载量(图4B),并且所有小鼠(3/3)在攻毒后第3天和第5天鼻甲检测到均值为4.41、3.39log(PFU/g)的活病毒量,肺检测到均值为5.97、3.75log(PFU/g)的病毒载量,均显著高于重组RABVs免疫小鼠各组织、时间点的病毒载量(图4C)。结果表明,rERAG333E/S6P灭活免疫小鼠具有完全的攻毒保护效力。
序列表
<110> 中国农业科学院哈尔滨兽医研究所(中国动物卫生与流行病学中心哈尔滨分中心)
<120> 新冠肺炎重组狂犬病病毒载体疫苗
<160> 6
<170> SIPOSequenceListing 1.0
<210> 1
<211> 3852
<212> DNA
<213> S’-TP-1(2 Ambystoma laterale x Ambystoma jeffersonianum)
<400> 1
atggacgcca tgaagcgcgg cctgtgctgc gtgctgctgc tgtgcggcgc cgtgttcgtg 60
tccgcccgcc agtgcgtgaa cctgaccacc cgcacccagc tgccccccgc ctacaccaac 120
tccttcaccc gcggcgtgta ctaccccgac aaggtgttcc gctcctccgt gctgcactcc 180
acccaggacc tgttcctgcc cttcttctcc aacgtgacct ggttccacgc catccacgtg 240
tccggcacca acggcaccaa gcgcttcgac aaccccgtgc tgcccttcaa cgacggcgtg 300
tacttcgcct ccaccgagaa gtccaacatc atccgcggct ggatcttcgg caccaccctg 360
gactccaaga cccagtccct gctgatcgtg aacaacgcca ccaacgtggt gatcaaggtg 420
tgcgagttcc agttctgcaa cgaccccttc ctgggcgtgt actaccacaa gaacaacaag 480
tcctggatgg agtccgagtt ccgcgtgtac tcctccgcca acaactgcac cttcgagtac 540
gtgtcccagc ccttcctgat ggacctggag ggcaagcagg gcaacttcaa gaacctgcgc 600
gagttcgtgt tcaagaacat cgacggctac ttcaagatct actccaagca cacccccatc 660
aacctggtgc gcgacctgcc ccagggcttc tccgccctgg agcccctggt ggacctgccc 720
atcggcatca acatcacccg cttccagacc ctgctggccc tgcaccgctc ctacctgacc 780
cccggcgact cctcctccgg ctggaccgcc ggcgccgccg cctactacgt gggctacctg 840
cagccccgca ccttcctgct gaagtacaac gagaacggca ccatcaccga cgccgtggac 900
tgcgccctgg accccctgtc cgagaccaag tgcaccctga agtccttcac cgtggagaag 960
ggcatctacc agacctccaa cttccgcgtg cagcccaccg agtccatcgt gcgcttcccc 1020
aacatcacca acctgtgccc cttcggcgag gtgttcaacg ccacccgctt cgcctccgtg 1080
tacgcctgga accgcaagcg catctccaac tgcgtggccg actactccgt gctgtacaac 1140
tccgcctcct tctccacctt caagtgctac ggcgtgtccc ccaccaagct gaacgacctg 1200
tgcttcacca acgtgtacgc cgactccttc gtgatccgcg gcgacgaggt gcgccagatc 1260
gcccccggcc agaccggcaa gatcgccgac tacaactaca agctgcccga cgacttcacc 1320
ggctgcgtga tcgcctggaa ctccaacaac ctggactcca aggtgggcgg caactacaac 1380
tacctgtacc gcctgttccg caagtccaac ctgaagccct tcgagcgcga catctccacc 1440
gagatctacc aggccggctc caccccctgc aacggcgtgg agggcttcaa ctgctacttc 1500
cccctgcagt cctacggctt ccagcccacc aacggcgtgg gctaccagcc ctaccgcgtg 1560
gtggtgctgt ccttcgagct gctgcacgcc cccgccaccg tgtgcggccc caagaagtcc 1620
accaacctgg tgaagaacaa gtgcgtgaac ttcaacttca acggcctgac cggcaccggc 1680
gtgctgaccg agtccaacaa gaagttcctg cccttccagc agttcggccg cgacatcgcc 1740
gacaccaccg acgccgtgcg cgacccccag accctggaga tcctggacat caccccctgc 1800
tccttcggcg gcgtgtccgt gatcaccccc ggcaccaaca cctccaacca ggtggccgtg 1860
ctgtaccagg acgtgaactg caccgaggtg cccgtggcca tccacgccga ccagctgacc 1920
cccacctggc gcgtgtactc caccggctcc aacgtgttcc agacccgcgc cggctgcctg 1980
atcggcgccg agcacgtgaa caactcctac gagtgcgaca tccccatcgg cgccggcatc 2040
tgcgcctcct accagaccca gaccaactcc ccccgccgcg cccgctccgt ggcctcccag 2100
tccatcatcg cctacaccat gtccctgggc gccgagaact ccgtggccta ctccaacaac 2160
tccatcgcca tccccaccaa cttcaccatc tccgtgacca ccgagatcct gcccgtgtcc 2220
atgaccaaga cctccgtgga ctgcaccatg tacatctgcg gcgactccac cgagtgctcc 2280
aacctgctgc tgcagtacgg ctccttctgc acccagctga accgcgccct gaccggcatc 2340
gccgtggagc aggacaagaa cacccaggag gtgttcgccc aggtgaagca gatctacaag 2400
acccccccca tcaaggactt cggcggcttc aacttctccc agatcctgcc cgacccctcc 2460
aagccctcca agcgctcctt catcgaggac ctgctgttca acaaggtgac cctggccgac 2520
gccggcttca tcaagcagta cggcgactgc ctgggcgaca tcgccgcccg cgacctgatc 2580
tgcgcccaga agttcaacgg cctgaccgtg ctgccccccc tgctgaccga cgagatgatc 2640
gcccagtaca cctccgccct gctggccggc accatcacct ccggctggac cttcggcgcc 2700
ggcgccgccc tgcagatccc cttcgccatg cagatggcct accgcttcaa cggcatcggc 2760
gtgacccaga acgtgctgta cgagaaccag aagctgatcg ccaaccagtt caactccgcc 2820
atcggcaaga tccaggactc cctgtcctcc accgcctccg ccctgggcaa gctgcaggac 2880
gtggtgaacc agaacgccca ggccctgaac accctggtga agcagctgtc ctccaacttc 2940
ggcgccatct cctccgtgct gaacgacatc ctgtcccgcc tggacaaggt ggaggccgag 3000
gtgcagatcg accgcctgat caccggccgc ctgcagtccc tgcagaccta cgtgacccag 3060
cagctgatcc gcgccgccga gatccgcgcc tccgccaacc tggccgccac caagatgtcc 3120
gagtgcgtgc tgggccagtc caagcgcgtg gacttctgcg gcaagggcta ccacctgatg 3180
tccttccccc agtccgcccc ccacggcgtg gtgttcctgc acgtgaccta cgtgcccgcc 3240
caggagaaga acttcaccac cgcccccgcc atctgccacg acggcaaggc ccacttcccc 3300
cgcgagggcg tgttcgtgtc caacggcacc cactggttcg tgacccagcg caacttctac 3360
gagccccaga tcatcaccac cgacaacacc ttcgtgtccg gcaactgcga cgtggtgatc 3420
ggcatcgtga acaacaccgt gtacgacccc ctgcagcccg agctggactc cttcaaggag 3480
gagctggaca agtacttcaa gaaccacacc tcccccgacg tggacctggg cgacatctcc 3540
ggcatcaacg cctccgtggt gaacatccag aaggagatcg accgcctgaa cgaggtggcc 3600
aagaacctga acgagtccct gatcgacctg caggagctgg gcaagtacga gcagtacatc 3660
aagtggccct ggtacatctg gctgggcttc atcgccggcc tgatcgccat cgtgatggtg 3720
accatcatgc tgtgctgcat gacctcctgc tgctcctgcc tgaagggctg ctgctcctgc 3780
ggctcctgct gcaagttcga cgaggacgac tccgagcccg tgctgaaggg cgtgaagctg 3840
cactacacct aa 3852
<210> 2
<211> 1283
<212> PRT
<213> SARS-CoV-2 S蛋白基因突变体tPASopti6(2 Ambystoma laterale xAmbystoma jeffersonianum)
<400> 2
Met Asp Ala Met Lys Arg Gly Leu Cys Cys Val Leu Leu Leu Cys Gly
1 5 10 15
Ala Val Phe Val Ser Ala Arg Gln Cys Val Asn Leu Thr Thr Arg Thr
20 25 30
Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr Tyr
35 40 45
Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp Leu
50 55 60
Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His Val
65 70 75 80
Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro Phe
85 90 95
Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile Arg
100 105 110
Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu Leu
115 120 125
Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe Gln
130 135 140
Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn Lys
145 150 155 160
Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn Cys
165 170 175
Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly Lys
180 185 190
Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile Asp
195 200 205
Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val Arg
210 215 220
Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu Pro
225 230 235 240
Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg
245 250 255
Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly Ala
260 265 270
Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys
275 280 285
Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu Asp
290 295 300
Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu Lys
305 310 315 320
Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser Ile
325 330 335
Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val Phe
340 345 350
Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile
355 360 365
Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe
370 375 380
Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp Leu
385 390 395 400
Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp Glu
405 410 415
Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn
420 425 430
Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn Ser
435 440 445
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg
450 455 460
Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr
465 470 475 480
Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly Phe
485 490 495
Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly
500 505 510
Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu Leu
515 520 525
His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu Val
530 535 540
Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr Gly
545 550 555 560
Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe Gly
565 570 575
Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr Leu
580 585 590
Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val Ile
595 600 605
Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln Asp
610 615 620
Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu Thr
625 630 635 640
Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr Arg
645 650 655
Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu Cys
660 665 670
Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln Thr
675 680 685
Asn Ser Pro Gly Ser Ala Ser Ser Val Ala Ser Gln Ser Ile Ile Ala
690 695 700
Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser Asn Asn
705 710 715 720
Ser Ile Ala Ile Pro Thr Asn Phe Thr Ile Ser Val Thr Thr Glu Ile
725 730 735
Leu Pro Val Ser Met Thr Lys Thr Ser Val Asp Cys Thr Met Tyr Ile
740 745 750
Cys Gly Asp Ser Thr Glu Cys Ser Asn Leu Leu Leu Gln Tyr Gly Ser
755 760 765
Phe Cys Thr Gln Leu Asn Arg Ala Leu Thr Gly Ile Ala Val Glu Gln
770 775 780
Asp Lys Asn Thr Gln Glu Val Phe Ala Gln Val Lys Gln Ile Tyr Lys
785 790 795 800
Thr Pro Pro Ile Lys Asp Phe Gly Gly Phe Asn Phe Ser Gln Ile Leu
805 810 815
Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Phe Ile Glu Asp Leu Leu
820 825 830
Phe Asn Lys Val Thr Leu Ala Asp Ala Gly Phe Ile Lys Gln Tyr Gly
835 840 845
Asp Cys Leu Gly Asp Ile Ala Ala Arg Asp Leu Ile Cys Ala Gln Lys
850 855 860
Phe Asn Gly Leu Thr Val Leu Pro Pro Leu Leu Thr Asp Glu Met Ile
865 870 875 880
Ala Gln Tyr Thr Ser Ala Leu Leu Ala Gly Thr Ile Thr Ser Gly Trp
885 890 895
Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile Pro Phe Ala Met Gln Met
900 905 910
Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr Glu
915 920 925
Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile
930 935 940
Gln Asp Ser Leu Ser Ser Thr Ala Ser Ala Leu Gly Lys Leu Gln Asp
945 950 955 960
Val Val Asn Gln Asn Ala Gln Ala Leu Asn Thr Leu Val Lys Gln Leu
965 970 975
Ser Ser Asn Phe Gly Ala Ile Ser Ser Val Leu Asn Asp Ile Leu Ser
980 985 990
Arg Leu Asp Lys Val Glu Ala Glu Val Gln Ile Asp Arg Leu Ile Thr
995 1000 1005
Gly Arg Leu Gln Ser Leu Gln Thr Tyr Val Thr Gln Gln Leu Ile Arg
1010 1015 1020
Ala Ala Glu Ile Arg Ala Ser Ala Asn Leu Ala Ala Thr Lys Met Ser
1025 1030 1035 1040
Glu Cys Val Leu Gly Gln Ser Lys Arg Val Asp Phe Cys Gly Lys Gly
1045 1050 1055
Tyr His Leu Met Ser Phe Pro Gln Ser Ala Pro His Gly Val Val Phe
1060 1065 1070
Leu His Val Thr Tyr Val Pro Ala Gln Glu Lys Asn Phe Thr Thr Ala
1075 1080 1085
Pro Ala Ile Cys His Asp Gly Lys Ala His Phe Pro Arg Glu Gly Val
1090 1095 1100
Phe Val Ser Asn Gly Thr His Trp Phe Val Thr Gln Arg Asn Phe Tyr
1105 1110 1115 1120
Glu Pro Gln Ile Ile Thr Thr Asp Asn Thr Phe Val Ser Gly Asn Cys
1125 1130 1135
Asp Val Val Ile Gly Ile Val Asn Asn Thr Val Tyr Asp Pro Leu Gln
1140 1145 1150
Pro Glu Leu Asp Ser Phe Lys Glu Glu Leu Asp Lys Tyr Phe Lys Asn
1155 1160 1165
His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile Ser Gly Ile Asn Ala
1170 1175 1180
Ser Val Val Asn Ile Gln Lys Glu Ile Asp Arg Leu Asn Glu Val Ala
1185 1190 1195 1200
Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu Gln Glu Leu Gly Lys Tyr
1205 1210 1215
Glu Gln Tyr Ile Lys Trp Pro Trp Tyr Ile Trp Leu Gly Phe Ile Ala
1220 1225 1230
Gly Leu Ile Ala Ile Val Met Val Thr Ile Met Leu Cys Cys Met Thr
1235 1240 1245
Ser Cys Cys Ser Cys Leu Lys Gly Cys Cys Ser Cys Gly Ser Cys Cys
1250 1255 1260
Lys Phe Asp Glu Asp Asp Ser Glu Pro Val Leu Lys Gly Val Lys Leu
1265 1270 1275 1280
His Tyr Thr
<210> 3
<211> 1283
<212> PRT
<213> 改造的SARS-CoV-2的刺突蛋白(2 Ambystoma laterale x Ambystomajeffersonianum)
<400> 3
Met Asp Ala Met Lys Arg Gly Leu Cys Cys Val Leu Leu Leu Cys Gly
1 5 10 15
Ala Val Phe Val Ser Ala Arg Gln Cys Val Asn Leu Thr Thr Arg Thr
20 25 30
Gln Leu Pro Pro Ala Tyr Thr Asn Ser Phe Thr Arg Gly Val Tyr Tyr
35 40 45
Pro Asp Lys Val Phe Arg Ser Ser Val Leu His Ser Thr Gln Asp Leu
50 55 60
Phe Leu Pro Phe Phe Ser Asn Val Thr Trp Phe His Ala Ile His Val
65 70 75 80
Ser Gly Thr Asn Gly Thr Lys Arg Phe Asp Asn Pro Val Leu Pro Phe
85 90 95
Asn Asp Gly Val Tyr Phe Ala Ser Thr Glu Lys Ser Asn Ile Ile Arg
100 105 110
Gly Trp Ile Phe Gly Thr Thr Leu Asp Ser Lys Thr Gln Ser Leu Leu
115 120 125
Ile Val Asn Asn Ala Thr Asn Val Val Ile Lys Val Cys Glu Phe Gln
130 135 140
Phe Cys Asn Asp Pro Phe Leu Gly Val Tyr Tyr His Lys Asn Asn Lys
145 150 155 160
Ser Trp Met Glu Ser Glu Phe Arg Val Tyr Ser Ser Ala Asn Asn Cys
165 170 175
Thr Phe Glu Tyr Val Ser Gln Pro Phe Leu Met Asp Leu Glu Gly Lys
180 185 190
Gln Gly Asn Phe Lys Asn Leu Arg Glu Phe Val Phe Lys Asn Ile Asp
195 200 205
Gly Tyr Phe Lys Ile Tyr Ser Lys His Thr Pro Ile Asn Leu Val Arg
210 215 220
Asp Leu Pro Gln Gly Phe Ser Ala Leu Glu Pro Leu Val Asp Leu Pro
225 230 235 240
Ile Gly Ile Asn Ile Thr Arg Phe Gln Thr Leu Leu Ala Leu His Arg
245 250 255
Ser Tyr Leu Thr Pro Gly Asp Ser Ser Ser Gly Trp Thr Ala Gly Ala
260 265 270
Ala Ala Tyr Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys
275 280 285
Tyr Asn Glu Asn Gly Thr Ile Thr Asp Ala Val Asp Cys Ala Leu Asp
290 295 300
Pro Leu Ser Glu Thr Lys Cys Thr Leu Lys Ser Phe Thr Val Glu Lys
305 310 315 320
Gly Ile Tyr Gln Thr Ser Asn Phe Arg Val Gln Pro Thr Glu Ser Ile
325 330 335
Val Arg Phe Pro Asn Ile Thr Asn Leu Cys Pro Phe Gly Glu Val Phe
340 345 350
Asn Ala Thr Arg Phe Ala Ser Val Tyr Ala Trp Asn Arg Lys Arg Ile
355 360 365
Ser Asn Cys Val Ala Asp Tyr Ser Val Leu Tyr Asn Ser Ala Ser Phe
370 375 380
Ser Thr Phe Lys Cys Tyr Gly Val Ser Pro Thr Lys Leu Asn Asp Leu
385 390 395 400
Cys Phe Thr Asn Val Tyr Ala Asp Ser Phe Val Ile Arg Gly Asp Glu
405 410 415
Val Arg Gln Ile Ala Pro Gly Gln Thr Gly Lys Ile Ala Asp Tyr Asn
420 425 430
Tyr Lys Leu Pro Asp Asp Phe Thr Gly Cys Val Ile Ala Trp Asn Ser
435 440 445
Asn Asn Leu Asp Ser Lys Val Gly Gly Asn Tyr Asn Tyr Leu Tyr Arg
450 455 460
Leu Phe Arg Lys Ser Asn Leu Lys Pro Phe Glu Arg Asp Ile Ser Thr
465 470 475 480
Glu Ile Tyr Gln Ala Gly Ser Thr Pro Cys Asn Gly Val Glu Gly Phe
485 490 495
Asn Cys Tyr Phe Pro Leu Gln Ser Tyr Gly Phe Gln Pro Thr Asn Gly
500 505 510
Val Gly Tyr Gln Pro Tyr Arg Val Val Val Leu Ser Phe Glu Leu Leu
515 520 525
His Ala Pro Ala Thr Val Cys Gly Pro Lys Lys Ser Thr Asn Leu Val
530 535 540
Lys Asn Lys Cys Val Asn Phe Asn Phe Asn Gly Leu Thr Gly Thr Gly
545 550 555 560
Val Leu Thr Glu Ser Asn Lys Lys Phe Leu Pro Phe Gln Gln Phe Gly
565 570 575
Arg Asp Ile Ala Asp Thr Thr Asp Ala Val Arg Asp Pro Gln Thr Leu
580 585 590
Glu Ile Leu Asp Ile Thr Pro Cys Ser Phe Gly Gly Val Ser Val Ile
595 600 605
Thr Pro Gly Thr Asn Thr Ser Asn Gln Val Ala Val Leu Tyr Gln Asp
610 615 620
Val Asn Cys Thr Glu Val Pro Val Ala Ile His Ala Asp Gln Leu Thr
625 630 635 640
Pro Thr Trp Arg Val Tyr Ser Thr Gly Ser Asn Val Phe Gln Thr Arg
645 650 655
Ala Gly Cys Leu Ile Gly Ala Glu His Val Asn Asn Ser Tyr Glu Cys
660 665 670
Asp Ile Pro Ile Gly Ala Gly Ile Cys Ala Ser Tyr Gln Thr Gln Thr
675 680 685
Asn Ser Pro Arg Arg Ala Arg Ser Val Ala Ser Gln Ser Ile Ile Ala
690 695 700
Tyr Thr Met Ser Leu Gly Ala Glu Asn Ser Val Ala Tyr Ser Asn Asn
705 710 715 720
Ser Ile Ala Ile Pro Thr Asn Phe Thr Ile Ser Val Thr Thr Glu Ile
725 730 735
Leu Pro Val Ser Met Thr Lys Thr Ser Val Asp Cys Thr Met Tyr Ile
740 745 750
Cys Gly Asp Ser Thr Glu Cys Ser Asn Leu Leu Leu Gln Tyr Gly Ser
755 760 765
Phe Cys Thr Gln Leu Asn Arg Ala Leu Thr Gly Ile Ala Val Glu Gln
770 775 780
Asp Lys Asn Thr Gln Glu Val Phe Ala Gln Val Lys Gln Ile Tyr Lys
785 790 795 800
Thr Pro Pro Ile Lys Asp Phe Gly Gly Phe Asn Phe Ser Gln Ile Leu
805 810 815
Pro Asp Pro Ser Lys Pro Ser Lys Arg Ser Phe Ile Glu Asp Leu Leu
820 825 830
Phe Asn Lys Val Thr Leu Ala Asp Ala Gly Phe Ile Lys Gln Tyr Gly
835 840 845
Asp Cys Leu Gly Asp Ile Ala Ala Arg Asp Leu Ile Cys Ala Gln Lys
850 855 860
Phe Asn Gly Leu Thr Val Leu Pro Pro Leu Leu Thr Asp Glu Met Ile
865 870 875 880
Ala Gln Tyr Thr Ser Ala Leu Leu Ala Gly Thr Ile Thr Ser Gly Trp
885 890 895
Thr Phe Gly Ala Gly Ala Ala Leu Gln Ile Pro Phe Ala Met Gln Met
900 905 910
Ala Tyr Arg Phe Asn Gly Ile Gly Val Thr Gln Asn Val Leu Tyr Glu
915 920 925
Asn Gln Lys Leu Ile Ala Asn Gln Phe Asn Ser Ala Ile Gly Lys Ile
930 935 940
Gln Asp Ser Leu Ser Ser Thr Ala Ser Ala Leu Gly Lys Leu Gln Asp
945 950 955 960
Val Val Asn Gln Asn Ala Gln Ala Leu Asn Thr Leu Val Lys Gln Leu
965 970 975
Ser Ser Asn Phe Gly Ala Ile Ser Ser Val Leu Asn Asp Ile Leu Ser
980 985 990
Arg Leu Asp Lys Val Glu Ala Glu Val Gln Ile Asp Arg Leu Ile Thr
995 1000 1005
Gly Arg Leu Gln Ser Leu Gln Thr Tyr Val Thr Gln Gln Leu Ile Arg
1010 1015 1020
Ala Ala Glu Ile Arg Ala Ser Ala Asn Leu Ala Ala Thr Lys Met Ser
1025 1030 1035 1040
Glu Cys Val Leu Gly Gln Ser Lys Arg Val Asp Phe Cys Gly Lys Gly
1045 1050 1055
Tyr His Leu Met Ser Phe Pro Gln Ser Ala Pro His Gly Val Val Phe
1060 1065 1070
Leu His Val Thr Tyr Val Pro Ala Gln Glu Lys Asn Phe Thr Thr Ala
1075 1080 1085
Pro Ala Ile Cys His Asp Gly Lys Ala His Phe Pro Arg Glu Gly Val
1090 1095 1100
Phe Val Ser Asn Gly Thr His Trp Phe Val Thr Gln Arg Asn Phe Tyr
1105 1110 1115 1120
Glu Pro Gln Ile Ile Thr Thr Asp Asn Thr Phe Val Ser Gly Asn Cys
1125 1130 1135
Asp Val Val Ile Gly Ile Val Asn Asn Thr Val Tyr Asp Pro Leu Gln
1140 1145 1150
Pro Glu Leu Asp Ser Phe Lys Glu Glu Leu Asp Lys Tyr Phe Lys Asn
1155 1160 1165
His Thr Ser Pro Asp Val Asp Leu Gly Asp Ile Ser Gly Ile Asn Ala
1170 1175 1180
Ser Val Val Asn Ile Gln Lys Glu Ile Asp Arg Leu Asn Glu Val Ala
1185 1190 1195 1200
Lys Asn Leu Asn Glu Ser Leu Ile Asp Leu Gln Glu Leu Gly Lys Tyr
1205 1210 1215
Glu Gln Tyr Ile Lys Trp Pro Trp Tyr Ile Trp Leu Gly Phe Ile Ala
1220 1225 1230
Gly Leu Ile Ala Ile Val Met Val Thr Ile Met Leu Cys Cys Met Thr
1235 1240 1245
Ser Cys Cys Ser Cys Leu Lys Gly Cys Cys Ser Cys Gly Ser Cys Cys
1250 1255 1260
Lys Phe Asp Glu Asp Asp Ser Glu Pro Val Leu Lys Gly Val Lys Leu
1265 1270 1275 1280
His Tyr Thr
<210> 4
<211> 15971
<212> DNA
<213> 重组RABV rERAG333E-S6P(2 Ambystoma laterale x Ambystomajeffersonianum)
<400> 4
tgttaagcgt ctgatgagtc cgtgaggacg aaactatagg aaaggaattc ctatagtcac 60
gcttaacaac cagatcaaag aaaaaacaga cattgtcaat tgcaaagcaa aaatgtaaca 120
cccctacaat ggatgccgac aagattgtat tcaaagtcaa taatcaggtg gtctctttga 180
agcctgagat tatcgtggat caatatgagt acaagtaccc tgccatcaaa gatttgaaaa 240
agccctgtat aaccctagga aaggctcccg atttaaataa agcatacaag tcagttttgt 300
caggcatgag cgccgccaaa cttgatcctg acgatgtatg ttcctatttg gcagcggcaa 360
tgcagttttt tgaggggaca tgtccggaag actggaccag ctatggaatc gtgattgcac 420
gaaaaggaga taagatcacc ccaggttctc tggtggagat aaaacgtact gatgtagaag 480
ggaattgggc tctgacagga ggcatggaac tgacaagaga ccccactgtc cctgagcatg 540
cgtccttagt cggtcttctc ttgagtctgt ataggttgag caaaatatcc gggcaaaaca 600
ctggtaacta taagacaaac attgcagaca ggatagagca gatttttgag acagcccctt 660
ttgttaaaat cgtagaacac catactctaa tgacaactca caaaatgtgt gctaattgga 720
gtactatacc aaacttcaga tttttggccg gaacctatga catgtttttc tcccggattg 780
agcatctata ttcagcaatc agagtgggca cagttgtcac tgcttatgaa gactgttcag 840
gactggtatc atttactggg ttcataaaac aaatcaatct caccgctaga gaggcaatac 900
tatatttctt ccacaagaac tttgaggaag agataagaag aatgtttgag ccagggcagg 960
agacagctgt tcctcactct tatttcatcc acttccgttc actaggcttg agtgggaaat 1020
ctccttattc atcaaatgct gttggtcacg tgttcaatct cattcacttt gtaggatgct 1080
atatgggtca agtcagatcc ctaaatgcaa cggttattgc tgcatgtgct cctcatgaaa 1140
tgtctgttct agggggctat ctgggagagg aattcttcgg gaaagggaca tttgaaagaa 1200
gattcttcag agatgagaaa gaacttcaag aatacgaggc ggctgaactg acaaagactg 1260
acgtagcact ggcagatgat ggaactgtca actctgacga cgaggactac ttctcaggtg 1320
aaaccagaag tccggaggct gtttatactc gaatcatgat gaatggaggt cgactaaaga 1380
gatctcacat acggagatat gtctcagtca gttccaatca tcaagcccgt ccaaactcat 1440
tcgccgagtt tctaaacaag acatattcga gtgactcata agaagttgaa taacaaaatg 1500
ccggaaatct acggattgtg tatatccatc atgaaaaaaa ctaacacccc tcctttcgaa 1560
ccatcccaaa catgagcaag atctttgtca atcctagtgc tattagagcc ggtctggccg 1620
atcttgagat ggctgaagaa actgttgatc tgatcaatag aaatatcgaa gacaatcagg 1680
ctcatctcca aggggaaccc atagaagtgg acaatctccc tgaggatatg gggcgacttc 1740
acctggatga tggaaaatcg cccaaccctg gtgagatggc caaggtggga gaaggcaagt 1800
atcgagagga ctttcagatg gatgaaggag aggatcctag cttcctgttc cagtcatacc 1860
tggaaaatgt tggagtccaa atagtcagac aaatgaggtc aggagagaga tttctcaaga 1920
tatggtcaca gaccgtagaa gagattatat cctatgtcgc ggtcaacttt cccaaccctc 1980
caggaaagtc ttcagaggat aaatcaaccc agactactgg ccgagagctc aagaaggaga 2040
caacacccac tccttctcag agagaaagcc aatcatcgaa agccaggatg gcggctcaaa 2100
ctgcgtctgg ccctccagcc cttgaatggt cggccgccaa tgaagaggat gatctatcag 2160
tggaggctga gatcgctcac cagattgcag aaagtttctc caaaaaatat aagtttccgt 2220
ctcgatcctc agggatactc ttgtataatt ttgagcaatt gaaaatgaac cttgatgata 2280
tagttaaaga ggcaaaaaat gtaccaggtg tgacccgttt agcccatgac gggtccaaac 2340
tccccctaag atgtgtactg ggatgggtcg ctttggccaa ctctaagaaa ttccagttgt 2400
tagtcgaatc cgacaagctg agtaaaatca tgcaagatga cttgaatcgc tatacatctt 2460
gctaaccgaa cctctccact cagtccctct agagtttaaa catgaaaaaa acaggcaaca 2520
ccactgccgc caccatggac gccatgaagc gcggcctgtg ctgcgtgctg ctgctgtgcg 2580
gcgccgtgtt cgtgtccgcc cgccagtgcg tgaacctgac cacccgcacc cagctgcccc 2640
ccgcctacac caactccttc acccgcggcg tgtactaccc cgacaaggtg ttccgctcct 2700
ccgtgctgca ctccacccag gacctgttcc tgcccttctt ctccaacgtg acctggttcc 2760
acgccatcca cgtgtccggc accaacggca ccaagcgctt cgacaacccc gtgctgccct 2820
tcaacgacgg cgtgtacttc gcctccaccg agaagtccaa catcatccgc ggctggatct 2880
tcggcaccac cctggactcc aagacccagt ccctgctgat cgtgaacaac gccaccaacg 2940
tggtgatcaa ggtgtgcgag ttccagttct gcaacgaccc cttcctgggc gtgtactacc 3000
acaagaacaa caagtcctgg atggagtccg agttccgcgt gtactcctcc gccaacaact 3060
gcaccttcga gtacgtgtcc cagcccttcc tgatggacct ggagggcaag cagggcaact 3120
tcaagaacct gcgcgagttc gtgttcaaga acatcgacgg ctacttcaag atctactcca 3180
agcacacccc catcaacctg gtgcgcgacc tgccccaggg cttctccgcc ctggagcccc 3240
tggtggacct gcccatcggc atcaacatca cccgcttcca gaccctgctg gccctgcacc 3300
gctcctacct gacccccggc gactcctcct ccggctggac cgccggcgcc gccgcctact 3360
acgtgggcta cctgcagccc cgcaccttcc tgctgaagta caacgagaac ggcaccatca 3420
ccgacgccgt ggactgcgcc ctggaccccc tgtccgagac caagtgcacc ctgaagtcct 3480
tcaccgtgga gaagggcatc taccagacct ccaacttccg cgtgcagccc accgagtcca 3540
tcgtgcgctt ccccaacatc accaacctgt gccccttcgg cgaggtgttc aacgccaccc 3600
gcttcgcctc cgtgtacgcc tggaaccgca agcgcatctc caactgcgtg gccgactact 3660
ccgtgctgta caactccgcc tccttctcca ccttcaagtg ctacggcgtg tcccccacca 3720
agctgaacga cctgtgcttc accaacgtgt acgccgactc cttcgtgatc cgcggcgacg 3780
aggtgcgcca gatcgccccc ggccagaccg gcaagatcgc cgactacaac tacaagctgc 3840
ccgacgactt caccggctgc gtgatcgcct ggaactccaa caacctggac tccaaggtgg 3900
gcggcaacta caactacctg taccgcctgt tccgcaagtc caacctgaag cccttcgagc 3960
gcgacatctc caccgagatc taccaggccg gctccacccc ctgcaacggc gtggagggct 4020
tcaactgcta cttccccctg cagtcctacg gcttccagcc caccaacggc gtgggctacc 4080
agccctaccg cgtggtggtg ctgtccttcg agctgctgca cgcccccgcc accgtgtgcg 4140
gccccaagaa gtccaccaac ctggtgaaga acaagtgcgt gaacttcaac ttcaacggcc 4200
tgaccggcac cggcgtgctg accgagtcca acaagaagtt cctgcccttc cagcagttcg 4260
gccgcgacat cgccgacacc accgacgccg tgcgcgaccc ccagaccctg gagatcctgg 4320
acatcacccc ctgctccttc ggcggcgtgt ccgtgatcac ccccggcacc aacacctcca 4380
accaggtggc cgtgctgtac caggacgtga actgcaccga ggtgcccgtg gccatccacg 4440
ccgaccagct gacccccacc tggcgcgtgt actccaccgg ctccaacgtg ttccagaccc 4500
gcgccggctg cctgatcggc gccgagcacg tgaacaactc ctacgagtgc gacatcccca 4560
tcggcgccgg catctgcgcc tcctaccaga cccagaccaa ctcccccggc tccgcctcct 4620
ccgtggcctc ccagtccatc atcgcctaca ccatgtccct gggcgccgag aactccgtgg 4680
cctactccaa caactccatc gccatcccca ccaacttcac catctccgtg accaccgaga 4740
tcctgcccgt gtccatgacc aagacctccg tggactgcac catgtacatc tgcggcgact 4800
ccaccgagtg ctccaacctg ctgctgcagt acggctcctt ctgcacccag ctgaaccgcg 4860
ccctgaccgg catcgccgtg gagcaggaca agaacaccca ggaggtgttc gcccaggtga 4920
agcagatcta caagaccccc cccatcaagg acttcggcgg cttcaacttc tcccagatcc 4980
tgcccgaccc ctccaagccc tccaagcgct ccttcatcga ggacctgctg ttcaacaagg 5040
tgaccctggc cgacgccggc ttcatcaagc agtacggcga ctgcctgggc gacatcgccg 5100
cccgcgacct gatctgcgcc cagaagttca acggcctgac cgtgctgccc cccctgctga 5160
ccgacgagat gatcgcccag tacacctccg ccctgctggc cggcaccatc acctccggct 5220
ggaccttcgg cgccggcgcc gccctgcaga tccccttcgc catgcagatg gcctaccgct 5280
tcaacggcat cggcgtgacc cagaacgtgc tgtacgagaa ccagaagctg atcgccaacc 5340
agttcaactc cgccatcggc aagatccagg actccctgtc ctccaccgcc tccgccctgg 5400
gcaagctgca ggacgtggtg aaccagaacg cccaggccct gaacaccctg gtgaagcagc 5460
tgtcctccaa cttcggcgcc atctcctccg tgctgaacga catcctgtcc cgcctggaca 5520
aggtggaggc cgaggtgcag atcgaccgcc tgatcaccgg ccgcctgcag tccctgcaga 5580
cctacgtgac ccagcagctg atccgcgccg ccgagatccg cgcctccgcc aacctggccg 5640
ccaccaagat gtccgagtgc gtgctgggcc agtccaagcg cgtggacttc tgcggcaagg 5700
gctaccacct gatgtccttc ccccagtccg ccccccacgg cgtggtgttc ctgcacgtga 5760
cctacgtgcc cgcccaggag aagaacttca ccaccgcccc cgccatctgc cacgacggca 5820
aggcccactt cccccgcgag ggcgtgttcg tgtccaacgg cacccactgg ttcgtgaccc 5880
agcgcaactt ctacgagccc cagatcatca ccaccgacaa caccttcgtg tccggcaact 5940
gcgacgtggt gatcggcatc gtgaacaaca ccgtgtacga ccccctgcag cccgagctgg 6000
actccttcaa ggaggagctg gacaagtact tcaagaacca cacctccccc gacgtggacc 6060
tgggcgacat ctccggcatc aacgcctccg tggtgaacat ccagaaggag atcgaccgcc 6120
tgaacgaggt ggccaagaac ctgaacgagt ccctgatcga cctgcaggag ctgggcaagt 6180
acgagcagta catcaagtgg ccctggtaca tctggctggg cttcatcgcc ggcctgatcg 6240
ccatcgtgat ggtgaccatc atgctgtgct gcatgacctc ctgctgctcc tgcctgaagg 6300
gctgctgctc ctgcggctcc tgctgcaagt tcgacgagga cgactccgag cccgtgctga 6360
agggcgtgaa gctgcactac acctaagttt aaactccgag atgtcctaaa gtcaacatga 6420
aaaaaacagg caacaccact gataaaatga actttctacg taagatagtg aaaaattgca 6480
gggacgagga cactcaaaaa ccctctcccg tgtcagcccc tctggatgac gatgacttgt 6540
ggcttccacc ccctgaatac gtcccgctga aagaacttac aagcaagaag aacatgagga 6600
acttttgtat caacggaggg gttaaagtgt gtagcccgaa tggttactcg ttcaggatcc 6660
tgcggcacat tctgaaatca ttcgacgaga tatattctgg gaatcatagg atgatcgggt 6720
tagtcaaagt agttattgga ctggctttgt caggatctcc agtccctgag ggcatgaact 6780
gggtatacaa attgaggaga acctttatct tccagtgggc tgattccagg ggccctcttg 6840
aaggggagga gttggaatac tctcaggaga tcacttggga tgatgatact gagttcgtcg 6900
gattgcaaat aagagtgatt gcaaaacagt gtcatatcca gggcagaatc tggtgtatca 6960
acatgaaccc gagagcatgt caactatggt ctgacatgtc tcttcagaca caaaggtccg 7020
aagaggacaa agattcctct ctgcttctag aataatcaga ttatatcccg caaatttatc 7080
acttgtttac ctctggagga gagaacatat gggctcaact ccaacccttg ggagcaatat 7140
aacaaaaaaa catgttatgg tgccattaaa ccgctgcatt tcatcaaagt caagttgatt 7200
acctttacat tttgatcctc ttggatgtga aaaaaactat taacatccct caaaagactc 7260
aaggaaagat ggttcctcag gctctcctgt ttgtacccct tctggttttt ccattgtgtt 7320
ttgggaaatt ccctatttac acgataccag acaagcttgg tccctggagc ccgattgaca 7380
tacatcacct cagatgccca aacaatttgg tagtggagga cgaaggatgc accaacctgt 7440
cagggttctc ctacatggaa cttaaagttg gatacatctt agccataaaa atgaacgggt 7500
tcacttgcac aggcgttgtg acggaggctg aaacctacac taacttcgtt ggttatgtca 7560
caaccacgtt caaaagaaag catttccgcc caacaccaga tgcatgtaga gccgcgtaca 7620
actggaagat ggccggtgac cccagatatg aagagtctct acacaatccg taccctgact 7680
accgctggct tcgaactgta aaaaccacca aggagtctct cgttatcata tctccaagtg 7740
tggcagattt ggacccatat gacagatccc ttcactcgag ggtcttccct agcgggaagt 7800
gctcaggagt agcggtgtct tctacctact gctccactaa ccacgattac accatttgga 7860
tgcccgagaa tccgagacta gggatgtctt gtgacatttt taccaatagt agagggaaga 7920
gagcatccaa agggagtgag acttgcggct ttgtagatga aagaggccta tataagtctt 7980
taaaaggagc atgcaaactc aagttatgtg gagttctagg acttagactt atggatggaa 8040
catgggtcgc gatgcaaaca tcaaatgaaa ccaaatggtg ccctcccgat cagttggtga 8100
acctgcacga ctttcgctca gacgaaattg agcaccttgt tgtagaggag ttggtcagga 8160
agagagagga gtgtctggat gtactagagt ccatcatgac aaccaagtca gtgagtttca 8220
gacgtctcag tcatttaaga aaacttgtcc ctgggtttgg aaaagcatat accatattca 8280
acaagacctt gatggaagcc gatgctcact acaagtcagt cgaaacttgg aatgagatcc 8340
tcccttcaaa agggtgttta agagttgggg ggaggtgtca tcctcatgtg aacggggtgt 8400
ttttcaatgg tataatatta ggacctgacg gcaatgtctt aatcccagag atgcaatcat 8460
ccctcctcca gcaacatatg gagttgttgg aatcctcggt tatccccctt gtgcaccccc 8520
tggcagaccc gtctaccgtt ttcaaggacg gtgacgaggc tgaggatttt gttgaagttc 8580
accttcccga tgtgcacaat caggtctcag gagttgactt gggtctcccg aactggggga 8640
agtatgtatt actgagtgca ggggccctga ctgccttgat gttgataatt ttcctgatga 8700
catgttgtag aagagtcaat cgatcagaac ctacgcaaca caatctcaga gggacaggga 8760
gggaggtgtc agtcactccc caaagcggga agatcatatc ttcatgggaa tcacacaaga 8820
gtgggggtga gaccagactg tgaggactgg ccgtcctttc aacgatccaa gtcctgaaga 8880
tcacctcccc ttggggggtt ctttttgaaa aaaaacctgg gttcaatagt cctccttgaa 8940
ctccatgcaa ctgggtagat tcaagagtca tgagattttc attaatcctc tcagttgatc 9000
aagcaagatc atgtagattc tcataatagg ggagatcttc tagcagtttc agtgactaac 9060
ggtactttca ttctccagga actgacacca acagttgtag acaaaccacg gggtgtctcg 9120
ggtgactctg tgcttgggca cagacaaagg tcatggtgtg ttccatgata gcggactcag 9180
gatgagttaa ttgagagagg cagtcttcct cccgtgaagg acataagcag tagctcacaa 9240
tcatctcgcg tctcagcaaa gtgtgcataa ttataaagtg ctgggtcatc taagcttttc 9300
agtcgagaaa aaaacattag atcagaagaa caactggcaa cacttctcaa cctgagacct 9360
acttcaagat gctcgatcct ggagaggtct atgatgaccc tattgaccca atcgagttag 9420
aggctgaacc cagaggaacc cccactgtcc ccaacatctt gaggaactct gactacaatc 9480
tcaactctcc tttgatagaa gatcctgcta gactaatgtt agaatggtta aaaacaggga 9540
atagacctta tcggatgact ctaacagaca attgctccag gtctttcaga gttttgaaag 9600
attatttcaa gaaggtagat ttgggttctc tcaaggtggg cggaatggct gcacagtcaa 9660
tgatttctct ctggttatat ggtgcccact ctgaatccaa caggagccgg agatgtataa 9720
cagacttggc ccatttctat tccaagtcgt cccccataga gaagctgttg aatctcacgc 9780
taggaaatag agggctgaga atccccccag agggagtgtt aagttgcctt gagagggttg 9840
attatgataa tgcatttgga aggtatcttg ccaacacgta ttcctcttac ttgttcttcc 9900
atgtaatcac cttatacatg aacgccctag actgggatga agaaaagacc atcctagcat 9960
tatggaaaga tttaacctca gtggacatcg ggaaggactt ggtaaagttc aaagaccaaa 10020
tatggggact gctgatcgta acaaaggact ttgtttactc ccaaagttcc aattgtcttt 10080
ttgacagaaa ctacacactt atgctaaaag atcttttctt gtctcgcttc aactccttaa 10140
tggtcttgct ctctccccca gagccccgat actcagatga cttgatatct caactatgcc 10200
agctgtacat tgctggggat caagtcttgt ctatgtgtgg aaactccggc tatgaagtca 10260
tcaaactatt ggagccatat gtcgtgaata gtttagtcca gagagcagaa aagtttaggc 10320
ctctcattca ttccttggga gactttcctg tatttataaa agacaaggta agtcaacttg 10380
aagagacgtt cggtccctgt gcaagaaggt tctttagggc tctggatcaa ttcgccaaca 10440
tacatgactt ggtttttgtg tatggctgtt acaggcattg ggggcaccca tatatagatt 10500
atcgaaaggg tctgtcaaaa ctatatgatc aggttcacat taaaaaagtg atagataagt 10560
cctaccagga gtgcttagca agcgacctag ccaggaggat ccttagatgg ggttttgata 10620
agtactccaa gtggtatctg gattcaagat tcctagcccg agaccacccc ttgactcctt 10680
atatcaaaac ccaaacatgg ccacccaaac atattgtaga cttggtgggg gatacatggc 10740
acaagctccc gatcacgcag atctttgaga ttcctgaatc aatggatccg tcagaaatat 10800
tggatgacaa atcacattct ttcaccagaa cgagactagc ttcttggctg tcagaaaacc 10860
gaggggggcc tgttcctagc gaaaaagtta ttatcacggc cctgtctaag ccgcctgtca 10920
atccccgaga gtttctgagg tctatagacc tcggaggatt gccagatgaa gacttgataa 10980
ttggcctcaa gccaaaggaa cgggaattga agattgaagg tcgattcttt gctctaatgt 11040
catggaatct aagattgtat tttgtcatca ctgaaaaact cttggccaac tacatcttgc 11100
cactttttga cgcgctgact atgacagaca acctgaacaa ggtgtttaaa aagctgatcg 11160
acagggtcac cgggcaaggg cttttggact attcaagggt cacatatgca tttcacctgg 11220
actatgaaaa gtggaacaac catcaaagat tagagtcaac agaggatgta ttttctgtcc 11280
tagatcaagt gtttggattg aagagagtgt tttctagaac acacgagttt tttcaaaagg 11340
cctggatcta ttattcagac agatcagacc tcatcgggtt acgggaggat caaatatact 11400
gcttagatgc gtccaacggc ccaacctgtt ggaatggcca ggatggcggg ctagaaggct 11460
tacggcagaa gggctggagt ctagtcagct tattgatgat agatagagaa tctcaaatca 11520
ggaacacaag aaccaaaata ctagctcaag gagacaacca ggttttatgt ccgacatata 11580
tgttgtcgcc agggctatct caagaggggc tcctctatga attggagaga atatcaagga 11640
atgcactttc gatatacaga gccgtcgagg aaggggcatc taagctaggg ctgatcatca 11700
agaaagaaga gaccatgtgt agttatgact tcctcatcta tggaaaaacc cctttgttta 11760
gaggtaacat attggtgcct gagtccaaaa gatgggccag agtctcttgc gtctctaatg 11820
accaaatagt caacctcgcc aatataatgt cgacagtgtc caccaatgcg ctaacagtgg 11880
cacaacactc tcaatctttg atcaaaccga tgagggattt tctgctcatg tcagtacagg 11940
cagtctttca ctacctgcta tttagcccaa tcttaaaggg aagagtttac aagattctga 12000
gcgctgaagg ggagagcttt ctcctagcca tgtcaaggat aatctatcta gatccttctt 12060
tgggaggggt atctggaatg tccctcggaa gattccatat acgacagttc tcagaccctg 12120
tctctgaagg gttatccttc tggagagaga tctggttaag ctcccacgag tcctggattc 12180
acgcgttgtg tcaagaggct ggaaacccag atcttggaga gagaacactc gagagcttca 12240
ctcgccttct agaagatcct accaccttaa atatcagagg aggggccagt cctaccattc 12300
tactcaagga tgcaatcaga aaggctttat atgacgaggt ggacaaggtg gagaattcag 12360
agtttcgaga ggcaatcctg ttgtccaaga cccatagaga taattttata ctcttcttaa 12420
catctgttga gcctctgttt cctcgatttc tcagtgagct attcagttcg tcttttttgg 12480
gaatccccga gtcaatcatt ggattgatac aaaactcccg aacgataaga aggcagttta 12540
aaaagagtct ctcaaaaact ttagaagagt ccttctacaa ctcagagatc cacgggatta 12600
gtcggatgac ccagacacct cagagggttg ggggggtgtg gccttgctct tcagagaggg 12660
cagatctact tagggagatc tcttggggaa gaaaagtggt aggcacgaca gttcctcacc 12720
cttctgagat gttggggtta cttcccaagt cctctatttc ttgcacttgt ggagcaacag 12780
gaggaggcaa tcctagagtt tctgtatcag tactyccgtc ctttgatcag tcattttttt 12840
cacgaggccc cctaaagggg tacttgggct cgtccacctc tatgtcgacc cagctattcc 12900
atgcatggga aaaagtcact aatgttcatg tggtgaagag agctctatcg ttaaaagaat 12960
ctataaactg gttcattact agagattcca acttggctca agctctaatt aggaacatta 13020
tgtctctgac aggccctgat ttccctctag aggaggcccc tgtcttcaaa aggacggggt 13080
cagccttgca taggttcaag tctgccagat acagcgaagg agggtattct tctgtctgcc 13140
cgaacctcct ctctcatatt tctgttagta cagacaccat gtctgatttg acccaagacg 13200
ggaagaacta cgatttcatg ttccagccat tgatgcttta tgcacagaca tggacatcag 13260
agctggtaca gagagacaca aggctaagag actctacgtt tcattggcac ctccgatgca 13320
acaggtgtgt gagacccatt gacgacgtga ccctggagac ctctcagatc ttcgagtttc 13380
cggatgtgtc gaaaagaata tccagaatgg tttctggggc tgtgcctcac ttccagaggc 13440
ttcccgatat ccgtctgaga ccaggagatt ttgaatctct aagcggtaga gaaaagtctc 13500
accatatcgg atcagctcag gggctcttat actcaatctt agtggcaatt cacgactcag 13560
gatacaatga tggaaccatc ttccctgtca acatatacgg caaggtttcc cctagagact 13620
atttgagagg gctcgcaagg ggagtattga taggatcctc gatttgcttc ttgacaagaa 13680
tgacaaatat caatattaat agacctcttg aattgatctc aggggtaatc tcatatattc 13740
tcctgaggct agataaccat ccctccttgt acataatgct cagagaaccg tctcttagag 13800
gagagatatt ttctatccct cagaaaatcc ccgccgctta tccaaccact atgaaagaag 13860
gcaacagatc aatcttgtgt tatctccaac atgtgctacg ctatgagcga gagataatca 13920
cggcgtctcc agagaatgac tggctatgga tcttttcaga ctttagaagt gccaaaatga 13980
cgtacctaac cctcattact taccagtctc atcttctact ccagagggtt gagagaaacc 14040
tatctaagag tatgagagat aacctgcgac aattgagttc cttgatgagg caggtgctgg 14100
gcgggcacgg agaagatacc ttagagtcag acgacaacat tcaacgactg ctaaaagact 14160
ctttacgaag gacaagatgg gtggatcaag aggtgcgcca tgcagctaga accatgactg 14220
gagattacag ccccaacaag aaggtgtccc gtaaggtagg atgttcagaa tgggtctgct 14280
ctgctcaaca ggttgcagtc tctacctcag caaacccggc ccctgtctcg gagcttgaca 14340
taagggccct ctctaagagg ttccagaacc ctttgatctc gggcttgaga gtggttcagt 14400
gggcaaccgg tgctcattat aagcttaagc ctattctaga tgatctcaat gttttcccat 14460
ctctctgcct tgtagttggg gacgggtcag gggggatatc aagggcagtc ctcaacatgt 14520
ttccagatgc caagcttgtg ttcaacagtc ttttagaggt gaatgacctg atggcttccg 14580
gaacacatcc actgcctcct tcagcaatca tgaggggagg aaatgatatc gtctccagag 14640
tgatagattt tgactcaatc tgggaaaaac cgtccgactt gagaaacttg gcaacctgga 14700
aatacttcca gtcagtccaa aagcaggtca acatgtccta tgacctcatt atttgcgatg 14760
cagaagttac tgacattgca tctatcaacc ggataaccct gttaatgtcc gattttgcat 14820
tgtctataga tggaccactc tatttggtct tcaaaactta tgggactatg ctagtaaatc 14880
caaactacaa ggctattcaa cacctgtcaa gagcgttccc ctcggtcaca gggtttatca 14940
cccaagtaac ttcgtctttt tcatctgagc tctacctccg attctccaaa cgagggaagt 15000
ttttcagaga tgctgagtac ttgacctctt ccacccttcg agaaatgagc cttgtgttat 15060
tcaattgtag cagccccaag agtgagatgc agagagctcg ttccttgaac tatcaggatc 15120
ttgtcagagg atttcctgaa gaaatcatat caaatcctta caatgagatg atcataactc 15180
tgattgacag tgatgtagaa tcttttctag tccacaagat ggttgatgat cttgagttac 15240
agaggggaac tctgtctaaa gtggctatca ttatagccat catgatagtt ttctccaaca 15300
gagtcttcaa cgtttccaaa cccctaactg accccttgtt ctatccaccg tctgatccca 15360
aaatcctgag gcacttcaac atatgttgca gtactatgat gtatctatct actgctttag 15420
gtgacgtccc tagcttcgca agacttcacg acctgtataa cagacctata acttattact 15480
tcagaaagca agtcattcga gggaacgttt atctatcttg gagttggtcc aacgacacct 15540
cagtgttcaa aagggtagcc tgtaattcta gcctgagtct gtcatctcac tggatcaggt 15600
tgatttacaa gatagtgaag actaccagac tcgttggcag catcaaggat ctatccagag 15660
aagtggaaag acaccttcat aggtacaaca ggtggatcac cctagaggat atcagatcta 15720
gatcatccct actagactac agttgcctgt gaaccggata ctcctggaag cctgcccatg 15780
ctaagactct tgtgtgatgt atcttgaaaa aaacaagatc ctaaatctga acctttggtt 15840
gtttgattgt ttttctcatt tttgttgttt atttgttaag cgtgggtcgg catggcatct 15900
ccacctcctc gcggtccgac ctgggcatcc gaaggaggac gcacgtccac tcggatggct 15960
aagggagggc g 15971
<210> 5
<211> 15971
<212> DNA
<213> 重组RABV rERAG333E-coS’(2 Ambystoma laterale x Ambystomajeffersonianum)
<400> 5
tgttaagcgt ctgatgagtc cgtgaggacg aaactatagg aaaggaattc ctatagtcac 60
gcttaacaac cagatcaaag aaaaaacaga cattgtcaat tgcaaagcaa aaatgtaaca 120
cccctacaat ggatgccgac aagattgtat tcaaagtcaa taatcaggtg gtctctttga 180
agcctgagat tatcgtggat caatatgagt acaagtaccc tgccatcaaa gatttgaaaa 240
agccctgtat aaccctagga aaggctcccg atttaaataa agcatacaag tcagttttgt 300
caggcatgag cgccgccaaa cttgatcctg acgatgtatg ttcctatttg gcagcggcaa 360
tgcagttttt tgaggggaca tgtccggaag actggaccag ctatggaatc gtgattgcac 420
gaaaaggaga taagatcacc ccaggttctc tggtggagat aaaacgtact gatgtagaag 480
ggaattgggc tctgacagga ggcatggaac tgacaagaga ccccactgtc cctgagcatg 540
cgtccttagt cggtcttctc ttgagtctgt ataggttgag caaaatatcc gggcaaaaca 600
ctggtaacta taagacaaac attgcagaca ggatagagca gatttttgag acagcccctt 660
ttgttaaaat cgtagaacac catactctaa tgacaactca caaaatgtgt gctaattgga 720
gtactatacc aaacttcaga tttttggccg gaacctatga catgtttttc tcccggattg 780
agcatctata ttcagcaatc agagtgggca cagttgtcac tgcttatgaa gactgttcag 840
gactggtatc atttactggg ttcataaaac aaatcaatct caccgctaga gaggcaatac 900
tatatttctt ccacaagaac tttgaggaag agataagaag aatgtttgag ccagggcagg 960
agacagctgt tcctcactct tatttcatcc acttccgttc actaggcttg agtgggaaat 1020
ctccttattc atcaaatgct gttggtcacg tgttcaatct cattcacttt gtaggatgct 1080
atatgggtca agtcagatcc ctaaatgcaa cggttattgc tgcatgtgct cctcatgaaa 1140
tgtctgttct agggggctat ctgggagagg aattcttcgg gaaagggaca tttgaaagaa 1200
gattcttcag agatgagaaa gaacttcaag aatacgaggc ggctgaactg acaaagactg 1260
acgtagcact ggcagatgat ggaactgtca actctgacga cgaggactac ttctcaggtg 1320
aaaccagaag tccggaggct gtttatactc gaatcatgat gaatggaggt cgactaaaga 1380
gatctcacat acggagatat gtctcagtca gttccaatca tcaagcccgt ccaaactcat 1440
tcgccgagtt tctaaacaag acatattcga gtgactcata agaagttgaa taacaaaatg 1500
ccggaaatct acggattgtg tatatccatc atgaaaaaaa ctaacacccc tcctttcgaa 1560
ccatcccaaa catgagcaag atctttgtca atcctagtgc tattagagcc ggtctggccg 1620
atcttgagat ggctgaagaa actgttgatc tgatcaatag aaatatcgaa gacaatcagg 1680
ctcatctcca aggggaaccc atagaagtgg acaatctccc tgaggatatg gggcgacttc 1740
acctggatga tggaaaatcg cccaaccctg gtgagatggc caaggtggga gaaggcaagt 1800
atcgagagga ctttcagatg gatgaaggag aggatcctag cttcctgttc cagtcatacc 1860
tggaaaatgt tggagtccaa atagtcagac aaatgaggtc aggagagaga tttctcaaga 1920
tatggtcaca gaccgtagaa gagattatat cctatgtcgc ggtcaacttt cccaaccctc 1980
caggaaagtc ttcagaggat aaatcaaccc agactactgg ccgagagctc aagaaggaga 2040
caacacccac tccttctcag agagaaagcc aatcatcgaa agccaggatg gcggctcaaa 2100
ctgcgtctgg ccctccagcc cttgaatggt cggccgccaa tgaagaggat gatctatcag 2160
tggaggctga gatcgctcac cagattgcag aaagtttctc caaaaaatat aagtttccgt 2220
ctcgatcctc agggatactc ttgtataatt ttgagcaatt gaaaatgaac cttgatgata 2280
tagttaaaga ggcaaaaaat gtaccaggtg tgacccgttt agcccatgac gggtccaaac 2340
tccccctaag atgtgtactg ggatgggtcg ctttggccaa ctctaagaaa ttccagttgt 2400
tagtcgaatc cgacaagctg agtaaaatca tgcaagatga cttgaatcgc tatacatctt 2460
gctaaccgaa cctctccact cagtccctct agagtttaaa catgaaaaaa acaggcaaca 2520
ccactgccgc caccatggac gccatgaagc gcggcctgtg ctgcgtgctg ctgctgtgcg 2580
gcgccgtgtt cgtgtccgcc cgccagtgcg tgaacctgac cacccgcacc cagctgcccc 2640
ccgcctacac caactccttc acccgcggcg tgtactaccc cgacaaggtg ttccgctcct 2700
ccgtgctgca ctccacccag gacctgttcc tgcccttctt ctccaacgtg acctggttcc 2760
acgccatcca cgtgtccggc accaacggca ccaagcgctt cgacaacccc gtgctgccct 2820
tcaacgacgg cgtgtacttc gcctccaccg agaagtccaa catcatccgc ggctggatct 2880
tcggcaccac cctggactcc aagacccagt ccctgctgat cgtgaacaac gccaccaacg 2940
tggtgatcaa ggtgtgcgag ttccagttct gcaacgaccc cttcctgggc gtgtactacc 3000
acaagaacaa caagtcctgg atggagtccg agttccgcgt gtactcctcc gccaacaact 3060
gcaccttcga gtacgtgtcc cagcccttcc tgatggacct ggagggcaag cagggcaact 3120
tcaagaacct gcgcgagttc gtgttcaaga acatcgacgg ctacttcaag atctactcca 3180
agcacacccc catcaacctg gtgcgcgacc tgccccaggg cttctccgcc ctggagcccc 3240
tggtggacct gcccatcggc atcaacatca cccgcttcca gaccctgctg gccctgcacc 3300
gctcctacct gacccccggc gactcctcct ccggctggac cgccggcgcc gccgcctact 3360
acgtgggcta cctgcagccc cgcaccttcc tgctgaagta caacgagaac ggcaccatca 3420
ccgacgccgt ggactgcgcc ctggaccccc tgtccgagac caagtgcacc ctgaagtcct 3480
tcaccgtgga gaagggcatc taccagacct ccaacttccg cgtgcagccc accgagtcca 3540
tcgtgcgctt ccccaacatc accaacctgt gccccttcgg cgaggtgttc aacgccaccc 3600
gcttcgcctc cgtgtacgcc tggaaccgca agcgcatctc caactgcgtg gccgactact 3660
ccgtgctgta caactccgcc tccttctcca ccttcaagtg ctacggcgtg tcccccacca 3720
agctgaacga cctgtgcttc accaacgtgt acgccgactc cttcgtgatc cgcggcgacg 3780
aggtgcgcca gatcgccccc ggccagaccg gcaagatcgc cgactacaac tacaagctgc 3840
ccgacgactt caccggctgc gtgatcgcct ggaactccaa caacctggac tccaaggtgg 3900
gcggcaacta caactacctg taccgcctgt tccgcaagtc caacctgaag cccttcgagc 3960
gcgacatctc caccgagatc taccaggccg gctccacccc ctgcaacggc gtggagggct 4020
tcaactgcta cttccccctg cagtcctacg gcttccagcc caccaacggc gtgggctacc 4080
agccctaccg cgtggtggtg ctgtccttcg agctgctgca cgcccccgcc accgtgtgcg 4140
gccccaagaa gtccaccaac ctggtgaaga acaagtgcgt gaacttcaac ttcaacggcc 4200
tgaccggcac cggcgtgctg accgagtcca acaagaagtt cctgcccttc cagcagttcg 4260
gccgcgacat cgccgacacc accgacgccg tgcgcgaccc ccagaccctg gagatcctgg 4320
acatcacccc ctgctccttc ggcggcgtgt ccgtgatcac ccccggcacc aacacctcca 4380
accaggtggc cgtgctgtac caggacgtga actgcaccga ggtgcccgtg gccatccacg 4440
ccgaccagct gacccccacc tggcgcgtgt actccaccgg ctccaacgtg ttccagaccc 4500
gcgccggctg cctgatcggc gccgagcacg tgaacaactc ctacgagtgc gacatcccca 4560
tcggcgccgg catctgcgcc tcctaccaga cccagaccaa ctccccccgc cgcgcccgct 4620
ccgtggcctc ccagtccatc atcgcctaca ccatgtccct gggcgccgag aactccgtgg 4680
cctactccaa caactccatc gccatcccca ccaacttcac catctccgtg accaccgaga 4740
tcctgcccgt gtccatgacc aagacctccg tggactgcac catgtacatc tgcggcgact 4800
ccaccgagtg ctccaacctg ctgctgcagt acggctcctt ctgcacccag ctgaaccgcg 4860
ccctgaccgg catcgccgtg gagcaggaca agaacaccca ggaggtgttc gcccaggtga 4920
agcagatcta caagaccccc cccatcaagg acttcggcgg cttcaacttc tcccagatcc 4980
tgcccgaccc ctccaagccc tccaagcgct ccttcatcga ggacctgctg ttcaacaagg 5040
tgaccctggc cgacgccggc ttcatcaagc agtacggcga ctgcctgggc gacatcgccg 5100
cccgcgacct gatctgcgcc cagaagttca acggcctgac cgtgctgccc cccctgctga 5160
ccgacgagat gatcgcccag tacacctccg ccctgctggc cggcaccatc acctccggct 5220
ggaccttcgg cgccggcgcc gccctgcaga tccccttcgc catgcagatg gcctaccgct 5280
tcaacggcat cggcgtgacc cagaacgtgc tgtacgagaa ccagaagctg atcgccaacc 5340
agttcaactc cgccatcggc aagatccagg actccctgtc ctccaccgcc tccgccctgg 5400
gcaagctgca ggacgtggtg aaccagaacg cccaggccct gaacaccctg gtgaagcagc 5460
tgtcctccaa cttcggcgcc atctcctccg tgctgaacga catcctgtcc cgcctggaca 5520
aggtggaggc cgaggtgcag atcgaccgcc tgatcaccgg ccgcctgcag tccctgcaga 5580
cctacgtgac ccagcagctg atccgcgccg ccgagatccg cgcctccgcc aacctggccg 5640
ccaccaagat gtccgagtgc gtgctgggcc agtccaagcg cgtggacttc tgcggcaagg 5700
gctaccacct gatgtccttc ccccagtccg ccccccacgg cgtggtgttc ctgcacgtga 5760
cctacgtgcc cgcccaggag aagaacttca ccaccgcccc cgccatctgc cacgacggca 5820
aggcccactt cccccgcgag ggcgtgttcg tgtccaacgg cacccactgg ttcgtgaccc 5880
agcgcaactt ctacgagccc cagatcatca ccaccgacaa caccttcgtg tccggcaact 5940
gcgacgtggt gatcggcatc gtgaacaaca ccgtgtacga ccccctgcag cccgagctgg 6000
actccttcaa ggaggagctg gacaagtact tcaagaacca cacctccccc gacgtggacc 6060
tgggcgacat ctccggcatc aacgcctccg tggtgaacat ccagaaggag atcgaccgcc 6120
tgaacgaggt ggccaagaac ctgaacgagt ccctgatcga cctgcaggag ctgggcaagt 6180
acgagcagta catcaagtgg ccctggtaca tctggctggg cttcatcgcc ggcctgatcg 6240
ccatcgtgat ggtgaccatc atgctgtgct gcatgacctc ctgctgctcc tgcctgaagg 6300
gctgctgctc ctgcggctcc tgctgcaagt tcgacgagga cgactccgag cccgtgctga 6360
agggcgtgaa gctgcactac acctaagttt aaactccgag atgtcctaaa gtcaacatga 6420
aaaaaacagg caacaccact gataaaatga actttctacg taagatagtg aaaaattgca 6480
gggacgagga cactcaaaaa ccctctcccg tgtcagcccc tctggatgac gatgacttgt 6540
ggcttccacc ccctgaatac gtcccgctga aagaacttac aagcaagaag aacatgagga 6600
acttttgtat caacggaggg gttaaagtgt gtagcccgaa tggttactcg ttcaggatcc 6660
tgcggcacat tctgaaatca ttcgacgaga tatattctgg gaatcatagg atgatcgggt 6720
tagtcaaagt agttattgga ctggctttgt caggatctcc agtccctgag ggcatgaact 6780
gggtatacaa attgaggaga acctttatct tccagtgggc tgattccagg ggccctcttg 6840
aaggggagga gttggaatac tctcaggaga tcacttggga tgatgatact gagttcgtcg 6900
gattgcaaat aagagtgatt gcaaaacagt gtcatatcca gggcagaatc tggtgtatca 6960
acatgaaccc gagagcatgt caactatggt ctgacatgtc tcttcagaca caaaggtccg 7020
aagaggacaa agattcctct ctgcttctag aataatcaga ttatatcccg caaatttatc 7080
acttgtttac ctctggagga gagaacatat gggctcaact ccaacccttg ggagcaatat 7140
aacaaaaaaa catgttatgg tgccattaaa ccgctgcatt tcatcaaagt caagttgatt 7200
acctttacat tttgatcctc ttggatgtga aaaaaactat taacatccct caaaagactc 7260
aaggaaagat ggttcctcag gctctcctgt ttgtacccct tctggttttt ccattgtgtt 7320
ttgggaaatt ccctatttac acgataccag acaagcttgg tccctggagc ccgattgaca 7380
tacatcacct cagatgccca aacaatttgg tagtggagga cgaaggatgc accaacctgt 7440
cagggttctc ctacatggaa cttaaagttg gatacatctt agccataaaa atgaacgggt 7500
tcacttgcac aggcgttgtg acggaggctg aaacctacac taacttcgtt ggttatgtca 7560
caaccacgtt caaaagaaag catttccgcc caacaccaga tgcatgtaga gccgcgtaca 7620
actggaagat ggccggtgac cccagatatg aagagtctct acacaatccg taccctgact 7680
accgctggct tcgaactgta aaaaccacca aggagtctct cgttatcata tctccaagtg 7740
tggcagattt ggacccatat gacagatccc ttcactcgag ggtcttccct agcgggaagt 7800
gctcaggagt agcggtgtct tctacctact gctccactaa ccacgattac accatttgga 7860
tgcccgagaa tccgagacta gggatgtctt gtgacatttt taccaatagt agagggaaga 7920
gagcatccaa agggagtgag acttgcggct ttgtagatga aagaggccta tataagtctt 7980
taaaaggagc atgcaaactc aagttatgtg gagttctagg acttagactt atggatggaa 8040
catgggtcgc gatgcaaaca tcaaatgaaa ccaaatggtg ccctcccgat cagttggtga 8100
acctgcacga ctttcgctca gacgaaattg agcaccttgt tgtagaggag ttggtcagga 8160
agagagagga gtgtctggat gtactagagt ccatcatgac aaccaagtca gtgagtttca 8220
gacgtctcag tcatttaaga aaacttgtcc ctgggtttgg aaaagcatat accatattca 8280
acaagacctt gatggaagcc gatgctcact acaagtcagt cgaaacttgg aatgagatcc 8340
tcccttcaaa agggtgttta agagttgggg ggaggtgtca tcctcatgtg aacggggtgt 8400
ttttcaatgg tataatatta ggacctgacg gcaatgtctt aatcccagag atgcaatcat 8460
ccctcctcca gcaacatatg gagttgttgg aatcctcggt tatccccctt gtgcaccccc 8520
tggcagaccc gtctaccgtt ttcaaggacg gtgacgaggc tgaggatttt gttgaagttc 8580
accttcccga tgtgcacaat caggtctcag gagttgactt gggtctcccg aactggggga 8640
agtatgtatt actgagtgca ggggccctga ctgccttgat gttgataatt ttcctgatga 8700
catgttgtag aagagtcaat cgatcagaac ctacgcaaca caatctcaga gggacaggga 8760
gggaggtgtc agtcactccc caaagcggga agatcatatc ttcatgggaa tcacacaaga 8820
gtgggggtga gaccagactg tgaggactgg ccgtcctttc aacgatccaa gtcctgaaga 8880
tcacctcccc ttggggggtt ctttttgaaa aaaaacctgg gttcaatagt cctccttgaa 8940
ctccatgcaa ctgggtagat tcaagagtca tgagattttc attaatcctc tcagttgatc 9000
aagcaagatc atgtagattc tcataatagg ggagatcttc tagcagtttc agtgactaac 9060
ggtactttca ttctccagga actgacacca acagttgtag acaaaccacg gggtgtctcg 9120
ggtgactctg tgcttgggca cagacaaagg tcatggtgtg ttccatgata gcggactcag 9180
gatgagttaa ttgagagagg cagtcttcct cccgtgaagg acataagcag tagctcacaa 9240
tcatctcgcg tctcagcaaa gtgtgcataa ttataaagtg ctgggtcatc taagcttttc 9300
agtcgagaaa aaaacattag atcagaagaa caactggcaa cacttctcaa cctgagacct 9360
acttcaagat gctcgatcct ggagaggtct atgatgaccc tattgaccca atcgagttag 9420
aggctgaacc cagaggaacc cccactgtcc ccaacatctt gaggaactct gactacaatc 9480
tcaactctcc tttgatagaa gatcctgcta gactaatgtt agaatggtta aaaacaggga 9540
atagacctta tcggatgact ctaacagaca attgctccag gtctttcaga gttttgaaag 9600
attatttcaa gaaggtagat ttgggttctc tcaaggtggg cggaatggct gcacagtcaa 9660
tgatttctct ctggttatat ggtgcccact ctgaatccaa caggagccgg agatgtataa 9720
cagacttggc ccatttctat tccaagtcgt cccccataga gaagctgttg aatctcacgc 9780
taggaaatag agggctgaga atccccccag agggagtgtt aagttgcctt gagagggttg 9840
attatgataa tgcatttgga aggtatcttg ccaacacgta ttcctcttac ttgttcttcc 9900
atgtaatcac cttatacatg aacgccctag actgggatga agaaaagacc atcctagcat 9960
tatggaaaga tttaacctca gtggacatcg ggaaggactt ggtaaagttc aaagaccaaa 10020
tatggggact gctgatcgta acaaaggact ttgtttactc ccaaagttcc aattgtcttt 10080
ttgacagaaa ctacacactt atgctaaaag atcttttctt gtctcgcttc aactccttaa 10140
tggtcttgct ctctccccca gagccccgat actcagatga cttgatatct caactatgcc 10200
agctgtacat tgctggggat caagtcttgt ctatgtgtgg aaactccggc tatgaagtca 10260
tcaaactatt ggagccatat gtcgtgaata gtttagtcca gagagcagaa aagtttaggc 10320
ctctcattca ttccttggga gactttcctg tatttataaa agacaaggta agtcaacttg 10380
aagagacgtt cggtccctgt gcaagaaggt tctttagggc tctggatcaa ttcgccaaca 10440
tacatgactt ggtttttgtg tatggctgtt acaggcattg ggggcaccca tatatagatt 10500
atcgaaaggg tctgtcaaaa ctatatgatc aggttcacat taaaaaagtg atagataagt 10560
cctaccagga gtgcttagca agcgacctag ccaggaggat ccttagatgg ggttttgata 10620
agtactccaa gtggtatctg gattcaagat tcctagcccg agaccacccc ttgactcctt 10680
atatcaaaac ccaaacatgg ccacccaaac atattgtaga cttggtgggg gatacatggc 10740
acaagctccc gatcacgcag atctttgaga ttcctgaatc aatggatccg tcagaaatat 10800
tggatgacaa atcacattct ttcaccagaa cgagactagc ttcttggctg tcagaaaacc 10860
gaggggggcc tgttcctagc gaaaaagtta ttatcacggc cctgtctaag ccgcctgtca 10920
atccccgaga gtttctgagg tctatagacc tcggaggatt gccagatgaa gacttgataa 10980
ttggcctcaa gccaaaggaa cgggaattga agattgaagg tcgattcttt gctctaatgt 11040
catggaatct aagattgtat tttgtcatca ctgaaaaact cttggccaac tacatcttgc 11100
cactttttga cgcgctgact atgacagaca acctgaacaa ggtgtttaaa aagctgatcg 11160
acagggtcac cgggcaaggg cttttggact attcaagggt cacatatgca tttcacctgg 11220
actatgaaaa gtggaacaac catcaaagat tagagtcaac agaggatgta ttttctgtcc 11280
tagatcaagt gtttggattg aagagagtgt tttctagaac acacgagttt tttcaaaagg 11340
cctggatcta ttattcagac agatcagacc tcatcgggtt acgggaggat caaatatact 11400
gcttagatgc gtccaacggc ccaacctgtt ggaatggcca ggatggcggg ctagaaggct 11460
tacggcagaa gggctggagt ctagtcagct tattgatgat agatagagaa tctcaaatca 11520
ggaacacaag aaccaaaata ctagctcaag gagacaacca ggttttatgt ccgacatata 11580
tgttgtcgcc agggctatct caagaggggc tcctctatga attggagaga atatcaagga 11640
atgcactttc gatatacaga gccgtcgagg aaggggcatc taagctaggg ctgatcatca 11700
agaaagaaga gaccatgtgt agttatgact tcctcatcta tggaaaaacc cctttgttta 11760
gaggtaacat attggtgcct gagtccaaaa gatgggccag agtctcttgc gtctctaatg 11820
accaaatagt caacctcgcc aatataatgt cgacagtgtc caccaatgcg ctaacagtgg 11880
cacaacactc tcaatctttg atcaaaccga tgagggattt tctgctcatg tcagtacagg 11940
cagtctttca ctacctgcta tttagcccaa tcttaaaggg aagagtttac aagattctga 12000
gcgctgaagg ggagagcttt ctcctagcca tgtcaaggat aatctatcta gatccttctt 12060
tgggaggggt atctggaatg tccctcggaa gattccatat acgacagttc tcagaccctg 12120
tctctgaagg gttatccttc tggagagaga tctggttaag ctcccacgag tcctggattc 12180
acgcgttgtg tcaagaggct ggaaacccag atcttggaga gagaacactc gagagcttca 12240
ctcgccttct agaagatcct accaccttaa atatcagagg aggggccagt cctaccattc 12300
tactcaagga tgcaatcaga aaggctttat atgacgaggt ggacaaggtg gagaattcag 12360
agtttcgaga ggcaatcctg ttgtccaaga cccatagaga taattttata ctcttcttaa 12420
catctgttga gcctctgttt cctcgatttc tcagtgagct attcagttcg tcttttttgg 12480
gaatccccga gtcaatcatt ggattgatac aaaactcccg aacgataaga aggcagttta 12540
aaaagagtct ctcaaaaact ttagaagagt ccttctacaa ctcagagatc cacgggatta 12600
gtcggatgac ccagacacct cagagggttg ggggggtgtg gccttgctct tcagagaggg 12660
cagatctact tagggagatc tcttggggaa gaaaagtggt aggcacgaca gttcctcacc 12720
cttctgagat gttggggtta cttcccaagt cctctatttc ttgcacttgt ggagcaacag 12780
gaggaggcaa tcctagagtt tctgtatcag tactyccgtc ctttgatcag tcattttttt 12840
cacgaggccc cctaaagggg tacttgggct cgtccacctc tatgtcgacc cagctattcc 12900
atgcatggga aaaagtcact aatgttcatg tggtgaagag agctctatcg ttaaaagaat 12960
ctataaactg gttcattact agagattcca acttggctca agctctaatt aggaacatta 13020
tgtctctgac aggccctgat ttccctctag aggaggcccc tgtcttcaaa aggacggggt 13080
cagccttgca taggttcaag tctgccagat acagcgaagg agggtattct tctgtctgcc 13140
cgaacctcct ctctcatatt tctgttagta cagacaccat gtctgatttg acccaagacg 13200
ggaagaacta cgatttcatg ttccagccat tgatgcttta tgcacagaca tggacatcag 13260
agctggtaca gagagacaca aggctaagag actctacgtt tcattggcac ctccgatgca 13320
acaggtgtgt gagacccatt gacgacgtga ccctggagac ctctcagatc ttcgagtttc 13380
cggatgtgtc gaaaagaata tccagaatgg tttctggggc tgtgcctcac ttccagaggc 13440
ttcccgatat ccgtctgaga ccaggagatt ttgaatctct aagcggtaga gaaaagtctc 13500
accatatcgg atcagctcag gggctcttat actcaatctt agtggcaatt cacgactcag 13560
gatacaatga tggaaccatc ttccctgtca acatatacgg caaggtttcc cctagagact 13620
atttgagagg gctcgcaagg ggagtattga taggatcctc gatttgcttc ttgacaagaa 13680
tgacaaatat caatattaat agacctcttg aattgatctc aggggtaatc tcatatattc 13740
tcctgaggct agataaccat ccctccttgt acataatgct cagagaaccg tctcttagag 13800
gagagatatt ttctatccct cagaaaatcc ccgccgctta tccaaccact atgaaagaag 13860
gcaacagatc aatcttgtgt tatctccaac atgtgctacg ctatgagcga gagataatca 13920
cggcgtctcc agagaatgac tggctatgga tcttttcaga ctttagaagt gccaaaatga 13980
cgtacctaac cctcattact taccagtctc atcttctact ccagagggtt gagagaaacc 14040
tatctaagag tatgagagat aacctgcgac aattgagttc cttgatgagg caggtgctgg 14100
gcgggcacgg agaagatacc ttagagtcag acgacaacat tcaacgactg ctaaaagact 14160
ctttacgaag gacaagatgg gtggatcaag aggtgcgcca tgcagctaga accatgactg 14220
gagattacag ccccaacaag aaggtgtccc gtaaggtagg atgttcagaa tgggtctgct 14280
ctgctcaaca ggttgcagtc tctacctcag caaacccggc ccctgtctcg gagcttgaca 14340
taagggccct ctctaagagg ttccagaacc ctttgatctc gggcttgaga gtggttcagt 14400
gggcaaccgg tgctcattat aagcttaagc ctattctaga tgatctcaat gttttcccat 14460
ctctctgcct tgtagttggg gacgggtcag gggggatatc aagggcagtc ctcaacatgt 14520
ttccagatgc caagcttgtg ttcaacagtc ttttagaggt gaatgacctg atggcttccg 14580
gaacacatcc actgcctcct tcagcaatca tgaggggagg aaatgatatc gtctccagag 14640
tgatagattt tgactcaatc tgggaaaaac cgtccgactt gagaaacttg gcaacctgga 14700
aatacttcca gtcagtccaa aagcaggtca acatgtccta tgacctcatt atttgcgatg 14760
cagaagttac tgacattgca tctatcaacc ggataaccct gttaatgtcc gattttgcat 14820
tgtctataga tggaccactc tatttggtct tcaaaactta tgggactatg ctagtaaatc 14880
caaactacaa ggctattcaa cacctgtcaa gagcgttccc ctcggtcaca gggtttatca 14940
cccaagtaac ttcgtctttt tcatctgagc tctacctccg attctccaaa cgagggaagt 15000
ttttcagaga tgctgagtac ttgacctctt ccacccttcg agaaatgagc cttgtgttat 15060
tcaattgtag cagccccaag agtgagatgc agagagctcg ttccttgaac tatcaggatc 15120
ttgtcagagg atttcctgaa gaaatcatat caaatcctta caatgagatg atcataactc 15180
tgattgacag tgatgtagaa tcttttctag tccacaagat ggttgatgat cttgagttac 15240
agaggggaac tctgtctaaa gtggctatca ttatagccat catgatagtt ttctccaaca 15300
gagtcttcaa cgtttccaaa cccctaactg accccttgtt ctatccaccg tctgatccca 15360
aaatcctgag gcacttcaac atatgttgca gtactatgat gtatctatct actgctttag 15420
gtgacgtccc tagcttcgca agacttcacg acctgtataa cagacctata acttattact 15480
tcagaaagca agtcattcga gggaacgttt atctatcttg gagttggtcc aacgacacct 15540
cagtgttcaa aagggtagcc tgtaattcta gcctgagtct gtcatctcac tggatcaggt 15600
tgatttacaa gatagtgaag actaccagac tcgttggcag catcaaggat ctatccagag 15660
aagtggaaag acaccttcat aggtacaaca ggtggatcac cctagaggat atcagatcta 15720
gatcatccct actagactac agttgcctgt gaaccggata ctcctggaag cctgcccatg 15780
ctaagactct tgtgtgatgt atcttgaaaa aaacaagatc ctaaatctga acctttggtt 15840
gtttgattgt ttttctcatt tttgttgttt atttgttaag cgtgggtcgg catggcatct 15900
ccacctcctc gcggtccgac ctgggcatcc gaaggaggac gcacgtccac tcggatggct 15960
aagggagggc g 15971
<210> 6
<211> 3852
<212> DNA
<213> SARS-CoV-2的刺突蛋白衍生物(2 Ambystoma laterale x Ambystomajeffersonianum)
<400> 6
atggacgcca tgaagcgcgg cctgtgctgc gtgctgctgc tgtgcggcgc cgtgttcgtg 60
tccgcccgcc agtgcgtgaa cctgaccacc cgcacccagc tgccccccgc ctacaccaac 120
tccttcaccc gcggcgtgta ctaccccgac aaggtgttcc gctcctccgt gctgcactcc 180
acccaggacc tgttcctgcc cttcttctcc aacgtgacct ggttccacgc catccacgtg 240
tccggcacca acggcaccaa gcgcttcgac aaccccgtgc tgcccttcaa cgacggcgtg 300
tacttcgcct ccaccgagaa gtccaacatc atccgcggct ggatcttcgg caccaccctg 360
gactccaaga cccagtccct gctgatcgtg aacaacgcca ccaacgtggt gatcaaggtg 420
tgcgagttcc agttctgcaa cgaccccttc ctgggcgtgt actaccacaa gaacaacaag 480
tcctggatgg agtccgagtt ccgcgtgtac tcctccgcca acaactgcac cttcgagtac 540
gtgtcccagc ccttcctgat ggacctggag ggcaagcagg gcaacttcaa gaacctgcgc 600
gagttcgtgt tcaagaacat cgacggctac ttcaagatct actccaagca cacccccatc 660
aacctggtgc gcgacctgcc ccagggcttc tccgccctgg agcccctggt ggacctgccc 720
atcggcatca acatcacccg cttccagacc ctgctggccc tgcaccgctc ctacctgacc 780
cccggcgact cctcctccgg ctggaccgcc ggcgccgccg cctactacgt gggctacctg 840
cagccccgca ccttcctgct gaagtacaac gagaacggca ccatcaccga cgccgtggac 900
tgcgccctgg accccctgtc cgagaccaag tgcaccctga agtccttcac cgtggagaag 960
ggcatctacc agacctccaa cttccgcgtg cagcccaccg agtccatcgt gcgcttcccc 1020
aacatcacca acctgtgccc cttcggcgag gtgttcaacg ccacccgctt cgcctccgtg 1080
tacgcctgga accgcaagcg catctccaac tgcgtggccg actactccgt gctgtacaac 1140
tccgcctcct tctccacctt caagtgctac ggcgtgtccc ccaccaagct gaacgacctg 1200
tgcttcacca acgtgtacgc cgactccttc gtgatccgcg gcgacgaggt gcgccagatc 1260
gcccccggcc agaccggcaa gatcgccgac tacaactaca agctgcccga cgacttcacc 1320
ggctgcgtga tcgcctggaa ctccaacaac ctggactcca aggtgggcgg caactacaac 1380
tacctgtacc gcctgttccg caagtccaac ctgaagccct tcgagcgcga catctccacc 1440
gagatctacc aggccggctc caccccctgc aacggcgtgg agggcttcaa ctgctacttc 1500
cccctgcagt cctacggctt ccagcccacc aacggcgtgg gctaccagcc ctaccgcgtg 1560
gtggtgctgt ccttcgagct gctgcacgcc cccgccaccg tgtgcggccc caagaagtcc 1620
accaacctgg tgaagaacaa gtgcgtgaac ttcaacttca acggcctgac cggcaccggc 1680
gtgctgaccg agtccaacaa gaagttcctg cccttccagc agttcggccg cgacatcgcc 1740
gacaccaccg acgccgtgcg cgacccccag accctggaga tcctggacat caccccctgc 1800
tccttcggcg gcgtgtccgt gatcaccccc ggcaccaaca cctccaacca ggtggccgtg 1860
ctgtaccagg acgtgaactg caccgaggtg cccgtggcca tccacgccga ccagctgacc 1920
cccacctggc gcgtgtactc caccggctcc aacgtgttcc agacccgcgc cggctgcctg 1980
atcggcgccg agcacgtgaa caactcctac gagtgcgaca tccccatcgg cgccggcatc 2040
tgcgcctcct accagaccca gaccaactcc cccggctccg cctcctccgt ggcctcccag 2100
tccatcatcg cctacaccat gtccctgggc gccgagaact ccgtggccta ctccaacaac 2160
tccatcgcca tccccaccaa cttcaccatc tccgtgacca ccgagatcct gcccgtgtcc 2220
atgaccaaga cctccgtgga ctgcaccatg tacatctgcg gcgactccac cgagtgctcc 2280
aacctgctgc tgcagtacgg ctccttctgc acccagctga accgcgccct gaccggcatc 2340
gccgtggagc aggacaagaa cacccaggag gtgttcgccc aggtgaagca gatctacaag 2400
acccccccca tcaaggactt cggcggcttc aacttctccc agatcctgcc cgacccctcc 2460
aagccctcca agcgctcctt catcgaggac ctgctgttca acaaggtgac cctggccgac 2520
gccggcttca tcaagcagta cggcgactgc ctgggcgaca tcgccgcccg cgacctgatc 2580
tgcgcccaga agttcaacgg cctgaccgtg ctgccccccc tgctgaccga cgagatgatc 2640
gcccagtaca cctccgccct gctggccggc accatcacct ccggctggac cttcggcgcc 2700
ggcgccgccc tgcagatccc cttcgccatg cagatggcct accgcttcaa cggcatcggc 2760
gtgacccaga acgtgctgta cgagaaccag aagctgatcg ccaaccagtt caactccgcc 2820
atcggcaaga tccaggactc cctgtcctcc accgcctccg ccctgggcaa gctgcaggac 2880
gtggtgaacc agaacgccca ggccctgaac accctggtga agcagctgtc ctccaacttc 2940
ggcgccatct cctccgtgct gaacgacatc ctgtcccgcc tggacaaggt ggaggccgag 3000
gtgcagatcg accgcctgat caccggccgc ctgcagtccc tgcagaccta cgtgacccag 3060
cagctgatcc gcgccgccga gatccgcgcc tccgccaacc tggccgccac caagatgtcc 3120
gagtgcgtgc tgggccagtc caagcgcgtg gacttctgcg gcaagggcta ccacctgatg 3180
tccttccccc agtccgcccc ccacggcgtg gtgttcctgc acgtgaccta cgtgcccgcc 3240
caggagaaga acttcaccac cgcccccgcc atctgccacg acggcaaggc ccacttcccc 3300
cgcgagggcg tgttcgtgtc caacggcacc cactggttcg tgacccagcg caacttctac 3360
gagccccaga tcatcaccac cgacaacacc ttcgtgtccg gcaactgcga cgtggtgatc 3420
ggcatcgtga acaacaccgt gtacgacccc ctgcagcccg agctggactc cttcaaggag 3480
gagctggaca agtacttcaa gaaccacacc tcccccgacg tggacctggg cgacatctcc 3540
ggcatcaacg cctccgtggt gaacatccag aaggagatcg accgcctgaa cgaggtggcc 3600
aagaacctga acgagtccct gatcgacctg caggagctgg gcaagtacga gcagtacatc 3660
aagtggccct ggtacatctg gctgggcttc atcgccggcc tgatcgccat cgtgatggtg 3720
accatcatgc tgtgctgcat gacctcctgc tgctcctgcc tgaagggctg ctgctcctgc 3780
ggctcctgct gcaagttcga cgaggacgac tccgagcccg tgctgaaggg cgtgaagctg 3840
cactacacct aa 3852

Claims (10)

1.一种包含改造的SARS-CoV-2的刺突蛋白(S’)的疫苗组合物,该改造的SARS-CoV-2的刺突蛋白(S’)包含组织型纤溶酶原激活因子信号肽。
2.如权利要求1所述的疫苗组合物,其中改造的SARS-CoV-2的刺突蛋白(S’)包括S蛋白基因信号肽替换为组织型纤溶酶原激活因子信号肽。
3.如权利要求1或2所述的疫苗组合物,该改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物包含来自SEQ ID NO:1或SEQ ID NO:2的核苷酸序列。
4.如权利要求1-3任一项所述的疫苗组合物,该改造的SARS-CoV-2的刺突蛋白(S’)或其免疫原性衍生物由病毒载体编码。
5.如权利要求4所述的疫苗组合物,所述病毒载体选自腺病毒载体、腺相关病毒载体、逆转录病毒载体、痘病毒载体、疱疹病毒载体、新城疫病毒载体、流感病毒载体、狂犬病病毒载体。
6.一种疫苗组合物,包含将狂犬病毒疫苗株(rERAG333E)的非致病性骨架与新型改造的SARS-CoV-2的刺突蛋白(S’)结合的重组嵌合型狂犬病毒。
7.如权利要求6所述的疫苗组合物,其包含编码非致病性狂犬病病毒载体RABVrERAG333E的核酸分子SEQ ID NO:3和编码改造的SARS-CoV-2的刺突蛋白(S’)的核酸分子SEQ ID NO:4。
8.如权利要求6所述的疫苗组合物,其包含编码非致病性狂犬病病毒载体RABVrERAG333E的核酸分子SEQ ID NO:3和编码改造的SARS-CoV-2的刺突蛋白(S’)的氨基酸序列如SEQ ID NO:5所示。
9.如权利要求1-8任一项所述的疫苗组合物,疫苗是口服疫苗、活疫苗、经修饰的活疫苗、灭活疫苗、减毒疫苗、或亚单位疫苗。
10.如权利要求1-9任一项所述的疫苗组合物,该疫苗组合物还可以包含至少一种额外的抗原,至少一种额外的抗原保护性地抵御可以引起哺乳动物疾病的微生物。
CN202111189847.5A 2021-04-08 2021-10-12 新冠肺炎重组狂犬病病毒载体疫苗 Active CN115040644B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110378842 2021-04-08
CN2021103788420 2021-04-08

Publications (2)

Publication Number Publication Date
CN115040644A true CN115040644A (zh) 2022-09-13
CN115040644B CN115040644B (zh) 2023-03-07

Family

ID=83156776

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111189847.5A Active CN115040644B (zh) 2021-04-08 2021-10-12 新冠肺炎重组狂犬病病毒载体疫苗

Country Status (1)

Country Link
CN (1) CN115040644B (zh)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101376880A (zh) * 2008-09-24 2009-03-04 中国农业科学院哈尔滨兽医研究所 表达狂犬病病毒糖蛋白(GP蛋白)的重组新城疫LaSota弱毒疫苗株
WO2017176596A1 (en) * 2016-04-04 2017-10-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and coronaviruses
CN111088283A (zh) * 2020-03-20 2020-05-01 苏州奥特铭医药科技有限公司 mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗
CN111218459A (zh) * 2020-03-18 2020-06-02 中国人民解放军军事科学院军事医学研究院 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗
CN111675765A (zh) * 2020-06-02 2020-09-18 南京凯地生物科技有限公司 靶向冠状病毒spike的武装嵌合抗原受体细胞及制备方法和应用
CN112480217A (zh) * 2020-11-30 2021-03-12 广州市锐博生物科技有限公司 基于SARS-CoV-2的S抗原蛋白的疫苗和组合物

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101376880A (zh) * 2008-09-24 2009-03-04 中国农业科学院哈尔滨兽医研究所 表达狂犬病病毒糖蛋白(GP蛋白)的重组新城疫LaSota弱毒疫苗株
WO2017176596A1 (en) * 2016-04-04 2017-10-12 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Multivalent vaccines for rabies virus and coronaviruses
CN111218459A (zh) * 2020-03-18 2020-06-02 中国人民解放军军事科学院军事医学研究院 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗
CN111088283A (zh) * 2020-03-20 2020-05-01 苏州奥特铭医药科技有限公司 mVSV病毒载体及其病毒载体疫苗、一种基于mVSV介导的新冠肺炎疫苗
CN111675765A (zh) * 2020-06-02 2020-09-18 南京凯地生物科技有限公司 靶向冠状病毒spike的武装嵌合抗原受体细胞及制备方法和应用
CN112480217A (zh) * 2020-11-30 2021-03-12 广州市锐博生物科技有限公司 基于SARS-CoV-2的S抗原蛋白的疫苗和组合物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHING-LIN HSIEH 等: "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes", 《SCIENCE》 *
DRISHYA KURUP 等: "Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model", 《PLOS PATHOG》 *
邱晓燕 等: "新型冠状病毒疫苗研发进展及其潜在不良反应", 《中国临床药学杂志》 *

Also Published As

Publication number Publication date
CN115040644B (zh) 2023-03-07

Similar Documents

Publication Publication Date Title
US10946089B2 (en) Recombinant modified vaccinia virus ankara (MVA) respiratory syncytial virus (RSV) vaccine
US5741492A (en) Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses
CN113444156B (zh) 新型冠状病毒肺炎重组人5型腺病毒疫苗
US20230285540A1 (en) Polynucleotides encoding sars-cov-2 antigens and use thereof in the medical field as vaccines
US10251948B2 (en) Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine
CN113336838B (zh) 新型冠状病毒肺炎重组痘苗病毒载体疫苗
CN115040644B (zh) 新冠肺炎重组狂犬病病毒载体疫苗
JP7317896B2 (ja) 組換え改変ワクシニアウイルスアンカラ(mva)rsウイルス(rsv)ワクチン
US11696947B2 (en) H52 IBV vaccine with heterologous spike protein
KR20230022206A (ko) 코로나바이러스 질환에 대응하는 재조합적 변형된 우두증 바이러스 앙카라 (mva) 백신
JP7137276B2 (ja) 血清型a口蹄疫ウイルス用モザイクワクチン
CN113913393B (zh) 新型冠状病毒肺炎的重组新城疫病毒疫苗
NL2014148B1 (en) Combination vaccine for camelids.

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant